US20070167981A1 - Catch members for occluder devices - Google Patents
Catch members for occluder devices Download PDFInfo
- Publication number
- US20070167981A1 US20070167981A1 US11/644,373 US64437306A US2007167981A1 US 20070167981 A1 US20070167981 A1 US 20070167981A1 US 64437306 A US64437306 A US 64437306A US 2007167981 A1 US2007167981 A1 US 2007167981A1
- Authority
- US
- United States
- Prior art keywords
- configuration
- catch
- occluder
- catch member
- proximal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000004323 axial length Effects 0.000 claims description 15
- 239000011295 pitch Substances 0.000 claims description 15
- 238000000137 annealing Methods 0.000 claims description 11
- 238000005520 cutting process Methods 0.000 claims description 8
- 230000006835 compression Effects 0.000 claims description 6
- 238000007906 compression Methods 0.000 claims description 6
- 230000001143 conditioned effect Effects 0.000 claims description 5
- 230000000994 depressogenic effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 29
- 208000008883 Patent Foramen Ovale Diseases 0.000 abstract description 27
- 229920000642 polymer Polymers 0.000 abstract description 13
- 208000035478 Interatrial communication Diseases 0.000 abstract description 7
- 206010003664 atrial septal defect Diseases 0.000 abstract description 7
- 208000013914 atrial heart septal defect Diseases 0.000 abstract description 5
- 230000007556 vascular defect Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 16
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 11
- 238000013461 design Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 238000003466 welding Methods 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 6
- 230000001746 atrial effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 210000005246 left atrium Anatomy 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 4
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 210000005245 right atrium Anatomy 0.000 description 4
- 229920000431 shape-memory polymer Polymers 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000004491 foramen ovale Anatomy 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- 229920002791 poly-4-hydroxybutyrate Polymers 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000002121 Paradoxical Embolism Diseases 0.000 description 2
- 229920000291 Poly(9,9-dioctylfluorene) Polymers 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000032109 Transient ischaemic attack Diseases 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 210000003157 atrial septum Anatomy 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002594 fluoroscopy Methods 0.000 description 2
- 208000025339 heart septal defect Diseases 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 239000012781 shape memory material Substances 0.000 description 2
- 201000010875 transient cerebral ischemia Diseases 0.000 description 2
- 201000003130 ventricular septal defect Diseases 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000007213 cerebrovascular event Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000002458 fetal heart Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 229940127216 oral anticoagulant drug Drugs 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000004088 pulmonary circulation Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 230000006441 vascular event Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable or resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00619—Locking means for locking the implement in expanded state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00623—Introducing or retrieving devices therefor
Definitions
- This invention relates generally to occlusion devices for the closure of physical anomalies, such as an atrial septal defect, a patent foramen ovale, and other septal and vascular defects.
- the invention also relates to mechanisms for deploying such devices and securing them in the deployed position.
- a patent foramen ovale illustrated in FIG. 1 , is a persistent, one-way, usually flap-like opening in the wall between the right atrium 11 and left atrium 13 of the heart 10 . Because left atrial (LA) pressure is normally higher than right atrial (RA) pressure, the flap usually stays closed. Under certain conditions, however, right atrial pressure can exceed left atrial pressure, creating the possibility that blood could pass from the right atrium 1 1 to the left atrium 13 and blood clots could enter the systemic circulation. It is desirable that this circumstance be eliminated.
- LA left atrial
- RA right atrial pressure
- the foramen ovale serves a desired purpose when a fetus is gestating. Because blood is oxygenated through the umbilical cord, and not through the developing lungs, the circulatory system of the fetal heart allows the blood to flow through the foramen ovale as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two over-lapping layers of tissue: septum primum 14 and septum secundum 16 . However, a PFO has been shown to persist in a number of adults.
- patients at such an increased risk are considered for prophylactic medical therapy to reduce the risk of a recurrent embolic event.
- These patients are commonly treated with oral anticoagulants, which potentially have adverse side effects, such as hemorrhaging, hematoma, and interactions with a variety of other drugs.
- oral anticoagulants which potentially have adverse side effects, such as hemorrhaging, hematoma, and interactions with a variety of other drugs.
- the use of these drugs can alter a person's recovery and necessitate adjustments in a person's daily living pattern.
- surgical may be necessary or desirable to close a PFO.
- the surgery would typically include suturing a PFO closed by attaching septum secundum to septum primum. This sutured attachment can be accomplished using either an interrupted or a continuous stitch and is a common way a surgeon shuts a PFO under direct visualization.
- Umbrella devices and a variety of other similar mechanical closure devices developed initially for percutaneous closure of atrial septal defects (ASDs), have been used in some instances to close PFOs. These devices potentially allow patients to avoid the side effects often associated with anticoagulation therapies and the risks of invasive surgery.
- umbrella devices and the like that are designed for ASDs are not optimally suited for use as PFO closure devices.
- septal closure devices present drawbacks, including technically complex implantation procedures. Additionally, there are significant complications due to thrombus, fractures of the components, conduction system disturbances, perforations of heart tissue, and residual leaks. Many devices have high septal profile and include large masses of foreign material, which may lead to unfavorable body adaptation of a device. Given that ASD devices are designed to occlude holes, many lack anatomic conformability to the flap-like anatomy of PFOs. Thus, when inserting an ASD device to close a PFO, the narrow opening and the thin flap may form impediments to proper deployment.
- the device Even if an occlusive seal is formed, the device may be deployed in the heart on an angle, leaving some components insecurely seated against the septum and, thereby, risking thrombus formation due to hemodynamic disturbances. Finally, some septal closure devices are complex to manufacture, which may result in inconsistent product performance.
- septal closure devices made from a tube. These devices generally have a low septal profile in a delivery configuration, and a high septal profile in a deployed configuration. Upon deployment, these devices seal a septal defect.
- the unique design of these tube-made devices requires an additional catch mechanism to catch the devices in their deployed configurations.
- catch member designs have been proposed to catch the tube-made septal closure devices in the deployed configuration, temporary and permanently. Making such catch members capable of forming a temporary lock during partial deployment and a more secure permanent lock after full deployment has proved challenging. Some designs are not sufficiently reliable and other designs cannot be manufactured effectively. Finally, some designs, while workable on paper, do not perform satisfactorily in the human body.
- septal closure devices and techniques disclosed herein are designed to address these and other deficiencies of prior art design and techniques for delivering and retrieving such devices.
- the present invention includes several delivery devices and techniques for delivering an implant into a desired location within the body.
- This delivery technique relates particularly to, but is not limited to, a septal occluder made from a polymer tube.
- These delivery techniques in addition to use with septal occluders, can be applied to other medical devices, such as other expandable devices constructed to be delivered in a reduced profile configuration to an expanded profile or delivered configuration.
- Catch members may be used to deploy and keep the device in place.
- the catch member maintains a reduced axial length of the device when the device is in the deployed configuration.
- varied constructions could be used to maintain the axial dimension of the device, such as different locking mechanisms.
- the catch member secures both sides of the device in the reduced profile configuration with a single element.
- the catch member has a smaller diameter at its proximal end compared to the diameter of the proximal end of the occluder. This configuration allows the proximal end of the occluder to slide over the proximal end of the catch member during deployment sequence.
- the catch member In a catching configuration, the catch member generally has a greater diameter at its proximal end compared to the diameter of the proximal end of the occluder, which keeps the occluder in its deployed configuration.
- the catching configuration can be temporary or permanent.
- a temporary catch configuration generally allows for the catch member to release, while a permanent catch configuration generally is not designed for release.
- Some embodiments have a temporary catch configuration, which allows for confirmation of proper deployment, and a permanent catch configuration, that is engaged when proper deployment is confirmed.
- a permanent catch configuration can, for example, have a greater diameter at the proximal end of the catch member than a temporary catch configuration.
- a temporary catch configuration is generally preferred during evaluation and repositioning of a device, such as an occluder, while a permanent catch configuration is generally preferred once the device is deployed.
- the catch member is formed from a tube.
- the tube includes a material selected from the group consisting of metals, shape memory materials, alloys, polymers, bioabsorbable polymers, and combinations thereof.
- the tube includes a shape memory polymer.
- the tube includes nitinol.
- the tube is formed by rolling a flat piece of material into a tubular form.
- the catch member is formed by cutting the tube. The catch member is placed in its deployment configuration by fixing the axial length of the device, for example by preventing the proximal end of the device from sliding over the proximal catch element.
- the catch member uses a partially cut tube, with an axis of the proximal portion of the tube at an angle with respect to the axis of the distal side of the tube. A portion of the proximal side of the tube catches the proximal end of the device and keeps it in a deployed position.
- the catch member uses a series of protrusions at its proximal end. Once the protrusions are released, for example by removing the delivery wire, the protrusions project radially outward from the proximal side of the tube and keep the device in its locked position by preventing the proximal end of the device from sliding over the protrusions.
- the protrusions are biased towards the proximal or the distal end of the catch member. In some embodiments, they may be twisted relative to the axis of the catch member.
- the catch member may include a bump and pre-curved tabs at its proximal side.
- the bump is interrupted by a largely planar lumen slicing through the proximal side of the catch member.
- the lumen allows compression of the catch member with the delivery wire attached to provide a temporary catch configuration.
- the tabs after the delivery wire is removed, the tabs automatically slide into the lumen to prevent or reduce compressibility of the catch member, thus providing a permanent catch configuration.
- the catch member may include a delivery wire and a catch tube that is threadedly secured to the delivery wire at two different locations.
- Each threaded connection has different pitches. Twisting of the delivery wire with respect to the catch tube creates a temporary or permanent catch depending on the selected design criteria. This system is especially adapted to construction with malleable materials.
- the protrusions can be threaded with different pitches to allow for modulation of the protrusion configuration by twisting the delivery wire.
- FIG. 1 is a schematic representation of a human heart including various septal defects
- FIG. 2 shows an occluder and a catch member according to one embodiment of the disclosure
- FIG. 3 illustrates an occluder and a catch member during the initial stage of deployment according to one embodiment of the invention
- FIG. 4 illustrates an occluder and a catch member with the distal side of the occluder in its deployed configuration according to one embodiment of the invention
- FIG. 5 illustrates an occluder and a catch member in a deployed configuration according to one embodiment of the invention
- FIG. 6 is a view of cuts made during manufacture of a catch member according to one embodiment of the invention.
- FIG. 7 is a view of a catch member according to one embodiment of the invention.
- FIG. 8 is a cross-sectional view of the catch member along lines 8 - 8 in FIG. 7 according to one embodiment of the invention.
- FIG. 9 is an exploded cross-sectional side view of the catch member along lines 9 - 9 in FIG. 8 according to one embodiment of the invention.
- FIG. 10 is a cross-sectional side view of one step in a deployment sequence according to one embodiment of the invention.
- FIG. 11 is a cross-sectional side view of one step in a deployment sequence according to one embodiment of the invention.
- FIG. 12A is a cross-sectional side view of a deployed occluder and a catch member according to one embodiment of the invention.
- FIG. 12B is a cross-sectional side view of a deployed occluder and a catch member according to one embodiment of the invention.
- FIG. 13 is an axial cross-sectional drawing of an occluder and a catch member, in a delivery configuration, according to one embodiment of the invention.
- FIGS. 14-17 are cross-sectional side views of various steps in a deployment sequence according to one embodiment of the invention.
- FIGS. 18-22 are cross-sectional side views of various steps in a retrieval sequence according to one embodiment of the invention.
- FIG. 23 is a cross-sectional side view of a detachment step according to one embodiment of the invention.
- FIG. 24 is an exploded view of an embodiment of the distal portion of the catch member according to one aspect of the invention.
- FIG. 25 is a view of the cut(s) made during the manufacture of a catch member according to one embodiment of the invention.
- FIG. 26 is a cross-sectional view of a step in the manufacture of the catch member according to one embodiment of the invention.
- FIG. 27 is an exploded cross-sectional view of the catch member according to one embodiment of the invention.
- FIG. 28 is an exploded cross-sectional side view of the catch member along lines 28 - 28 in FIG. 27 according to one embodiment of the invention.
- FIGS. 29-30 are cross-sectional side views of various steps in the deployment sequence according to one embodiment of the invention.
- FIG. 31 is a cross-sectional side view of the delivery system during the detachment process according to one embodiment of the invention.
- FIG. 32 is a view of cuts made during manufacture of a catch member according to one embodiment of the invention.
- FIG. 33 is a view of a step in the manufacture of a catch member according to one embodiment of the invention.
- FIG. 34 is an expanded cross-sectional side view of the catch member according to one embodiment of the invention.
- FIG. 35 is an exploded cross-sectional side view of the catch member along lines 35 - 35 in FIG. 34 according to one embodiment of the invention.
- FIGS. 36-37 are cross-sectional side views of various steps in the deployment sequence according to one embodiment of the invention.
- FIG. 38 is a cross-sectional side view of the delivery system during the detachment process according to one embodiment of the invention.
- FIG. 39 is a view of a catch member according to one embodiment of the invention.
- FIG. 40 is a view of a catch member according to one embodiment of the invention.
- FIG. 41 is a view of cuts made during manufacture of a catch member according to one embodiment of the invention.
- FIG. 42 is a view of a catch member according to one embodiment of the invention.
- FIG. 43A illustrates an embodiment of the proximal catch element in a starting configuration according to one aspect of the invention
- FIG. 43B illustrates an embodiment of the proximal catch element in a temporary catch configuration according to one aspect of the invention
- FIG. 44 illustrates an embodiment of the proximal catch element in a permanent catch configuration according to one aspect of the invention
- FIG. 45A illustrates a step in the manufacture of the catch member according to one embodiment of the invention
- FIGS. 45B, 45D , 45 F and 45 H illustrate an embodiment of the catch member in a permanent catch configuration according to one aspect of the invention.
- FIGS. 45C, 45E , 45 G and 45 I illustrate an embodiment of the catch member in a temporary catch configuration according to one aspect of the invention.
- aspects of the present invention provide devices, delivery/retrieval systems and techniques for delivering such devices intended to occlude an aperture within body tissue.
- the described occluder may be used for closing an ASD, VSD or PFO in the atrial septum of a heart.
- the embodiments are described with reference to an ASD, VSD or PFO, one skilled in the art will recognize that the device and methods of the present invention may be used to treat other anatomical conditions. As such, the invention should not be considered limited in applicability to any particular anatomical condition.
- the systems and methods for delivery and retrieval, and for catching a device in a deployed state, that are aspects of the present invention may also be used in connection with other types of devices besides an occluder, in particular, devices having tubular profiles.
- FIG. 1 illustrates a human heart 10 , having a right atrium 11 and a left atrium 13 and including various anatomical apertures 18 a and 18 b .
- the atrial septum 12 includes septum primum 14 and septum secundum 16 .
- the anatomy of the septum 12 varies widely within the population. In some people, septum primum 14 extends to and overlaps with septum secundum 16 .
- the septum primum 14 may be quite thin.
- the anatomical apertures 18 a blood could travel through the anatomical aperture 18 a between septum primum 14 and septum secundum 16 (referred to as “the PFO tunnel”). Additionally, or alternatively, the presence of an ASD could permit blood to travel through an aperture in the septal tissue, such as through the anatomical aperture 18 b.
- distal refers to the direction away from a catheter insertion location and “proximal” refers to the direction nearer the insertion location.
- delivery configuration refers to the configuration of a device, such as an occluder, when it has a reduced profile in a delivery sheath or catheter.
- deployment configuration refers to the configuration of the device, such as an occluder, when it has deployed from the catheter, such as at the desired implantation location.
- FIGS. 2-5 illustrate an exemplary occluder with which systems and techniques disclosed herein may be used.
- a catch member 50 contains a proximal catch element 52 and a distal catch element, such as a flange 54 , and is designed to be disposed at the distal end of tube 25 of occluder 70 .
- Occluder 70 can be formed by cutting a series of slits on tube 25 .
- distal petals 32 are produced by cutting slits 31 in the upper portion of tube 25 according to the cutting pattern shown in FIG. 2 .
- the distal portion of the tube 25 is cut in half to form half sections 91 a and 91 b .
- the half sections 91 a and 91 b are further cut to a proximal distance from distal tip 39 into quarter sections 92 a , 93 a , 92 b , and 93 b .
- the cuts are discontinued and quarter sections 92 a and 92 b form half section 94 a at distal tip 39
- quarter sections 93 a and 93 b form half section 94 b at distal tip 39 .
- struts defined by slits 31 bow and twist outward to form distal petals 32 in distal side 30 , as shown in FIGS. 4-5 .
- Central tube 22 may be constrained during the application of force F d , or any combination of forces sufficient to reduce the axial length of the tube 25 may be applied.
- One end of each of distal petals 32 originates from central tube 22 , while the other end originates from distal tip 39 ( FIGS. 3-4 ).
- Proximal petals 42 may be formed in proximal side 40 , as shown in FIGS. 3-5 , making slits 41 between central tube 22 and proximal tip 44 , using the same cutting pattern described above.
- the tube(s) 25 forming occluder 70 may be formed from a biocompatible metal or polymer.
- occluder 70 is formed of a bioabsorbable polymer, or a shape memory polymer. Shape memory polymers can be advantageous so that the structure of the device assists in pressing the PFO tunnel closed.
- occluder 70 is formed of a biocompatible metal, such as a shape memory alloy (e.g., nitinol).
- shape memory alloy e.g., nitinol
- occluder 70 may be formed of a bioabsorbable metal, such as iron, magnesium, or combinations of these and similar materials.
- exemplary bioabsorbable polymers include polyhydroxyalkanoate compositions, for example poly-4-hydroxybutyrate (P4HB) compositions, disclosed in U.S. Pat. No. 6,610,764, entitled Polyhydroxyalkanoate Compositions Having Controlled Degradation Rate and U.S. Pat. No. 6,548,569, entitled Medical Devices and Applications of polyhydroxyalkanoate Polymers, both of which are incorporated by reference in their entirety.
- P4HB poly-4-hydroxybutyrate
- the cross-sectional shape of tube 25 may be circular or polygonal, for example square, pr hexagonal.
- the slits 31 and 41 may be disposed on the face of the polygon (i.e., the flat part) or on the intersection of the faces.
- the tube can be injection molded, extruded, or constructed of a sheet of material and rolled into a tube.
- the sheet of material could be a single ply sheet or multiple ply.
- the slits that form the struts could be cut or stamped into the sheet prior to rolling the sheet into a tube to connect the ends to form an enclosed cross section.
- Various geometrical cross sections are possible including circular, square, hexagonal and octagonal and the joint could be at the vertex or along the flat of a wall if the cross section is of a particular geometry.
- Various attachment techniques could be used to join the ends of the sheet to form a tube, including welding, heat adhesives, non-heat adhesives and other joining techniques suitable for in-vivo application.
- the petal configuration is the deployed configuration.
- Occluder 70 can be secured in the petal configuration by a catch member that holds the ends of the tube 25 together, certain embodiments of which are described below.
- FIGS. 2-5 has similarities to the devices disclosed in U.S. patent application Ser. No. 10/890,784, entitled Tubular Patent Foramen Ovale (PFO) Closure Device with Locking Mechanism, filed on Jul. 14, 2004; U.S. patent application Ser. No. 11/070,027, entitled Delivery/Recovery System for Clover Leaf Septal Occluder, filed on Mar. 2, 2005; U.S. patent application Ser. No. 11/235,661, entitled Occluder Device Double Securement System for Delivery/Recovery of Such Occluder Device, filed Sep. 16, 2005; U.S. patent application Ser. No. 11/384,635, filed Mar. 20, 2006, entitled Catch Member for PFO Occluder; U.S.
- one end of each of distal petals originates from a central tube, while the other end originates from the distal end.
- extended segments defined by slits in the tube bow and twist outward to form the distal petals in the distal side of the occluder.
- the movement of the segments during deployment is such that the segments rotate in an orthogonal plane relative to the axis of the device.
- the central tube may be constrained during the application of force, or any combination of forces sufficient to reduce the axial length of the tube may be applied. This embodiment is illustrated, for example, in FIGS. 2E-2H of U.S. patent application Ser. No. 11/395,718, which has been incorporated by reference above.
- occluder 70 enables occluder 70 to be delivered in a low profile, tubular form and to be converted readily, i.e., by reducing the axial length, in place to the high-profile deployed configuration. Moreover, the conversion can readily be effected by forcing distal tip 39 and proximal tip 44 together.
- distal side 30 and proximal side 40 of occluder 70 may be deployed in separate steps, or both distal side 30 and proximal side 40 of occluder 70 may be exposed (e.g., out of the delivery catheter) prior to engaging the catch member and deployed together as the catch member is engaged.
- Occluder 70 may be prepared for delivery to an aperture 18 a or 18 b in any one of several ways.
- Slits 31 and 41 may be cut such that tube 25 bends into its intended configuration following deployment in vivo.
- slits 31 and 41 may be cut to produce struts 32 and 42 of a thickness that facilitates the bending and formation of loops 32 and 42 upon the application of forces F d and/or F p during deployment. See FIGS. 3 and 4 .
- a tube 25 formed of a shape memory material may be preformed into its intended configuration ex vivo so that it will recover its preformed shape once deployed in vivo.
- this preforming technique produces more reliable deployment and bending of occluder 70 in vivo.
- An intermediate approach may also be used: tube 25 may be only slightly preformed ex vivo such that it is predisposed to bend into its intended shape in vivo upon application of forces F d and F p .
- FIGS. 6-9 An embodiment of the catch member according to one aspect of the invention is illustrated in FIGS. 6-9 .
- FIGS. 6 and 7 illustrate aspects of the manufacture of the catch member 100 .
- slits 103 which include a transverse slit 103 a and axial slits 103 b ) are cut into the proximal side 106 of the catch tube 102 to create arms 104 , each arm having a distal surface 104 a .
- Two arms 104 are illustrated. Of course, any number greater than one is possible.
- the geometrical constraints of the tube and manufacturing constraints of the slits would allow for up to 8 arms.
- Catch tube 102 is illustrated with a threaded portion 117 , which is used to secure the delivery wire to the catch member, a central lumen 112 into which the delivery wire is adapted to go and a distal catch element 110 at the distal side 108 of the tube that serves to hold the distal end of the catch member to the occluder.
- the threaded portion 117 can be located at the proximal side 106 or the distal side 108 of the catch tube 102 .
- arms 104 By pushing arms 104 towards the proximal side 106 of the tube, arms 104 can be conditioned into a bent configuration as illustrated on FIG. 7 .
- FIG. 8 illustrates the axial view of the arms 104 along lines 8 - 8 in FIG. 7 .
- the conditioning process may include and can be enhanced by an annealing process, which can provide additional shape stability to the arms 104 .
- arms 104 expand beyond the outside diameter of the catch tube 102 .
- An expanded cross-sectional view of arms 104 in the bent configuration along lines 9 - 9 in FIG. 8 is shown in FIG. 9 .
- FIG. 9 illustrates recess 118 created by the conditioning of arms 104 into the bent configuration.
- the arms can also be called “tabs”, “stays”, “holders”, or any other suitable word or phrase.
- the distal side 108 of the catch tube may be ultrasonically welded to occluder 70 , or some other fixing agent, such as glue, can be used.
- the catch tube 102 is slidably disposed within the central tube 22 of occluder 70 , and therefore, central tube 22 is able to slide against the catch tube 102 during the deployment and retrieval of occluder 70 .
- FIGS. 10 and 11 illustrate steps in the deployment of the catching mechanism according to one embodiment of the disclosure.
- Occluder 70 is introduced to an aperture 18 a or 18 b by a delivery sheath 154 in its delivery configuration.
- the delivery catheter 152 is positioned within the delivery sheath 154 with minimal clearance between them.
- the distal end of the delivery catheter 152 includes a threaded portion 153 .
- the threaded portion 153 is connected with the threaded portion 150 of the proximal tip 44 of the occluder.
- the distal tip 39 of the occluder is threadably connected to the delivery wire 156 at the threaded portion 117 of the catch tube 102 . As shown in FIG.
- the delivery wire has a recess 157 , illustrated as a narrowing in the circumference, into which the arms 104 are rested, in unlocked position, during the delivery process.
- the recess 157 can vary in size and in some designs may be optional.
- the threaded portion 117 can be located at the proximal side 106 or at the distal side 108 of the catch tube 102 .
- the distal side 30 of occluder 70 is exposed by withdrawing delivery sheath 152 proximally while holding delivery catheter 154 and delivery wire 156 stable.
- the distal side 30 of occluder 70 is deployed by advancing delivery catheter 154 distally to reduce the axial length between the central tube 22 and the distal tip 39 of occluder 70 , while holding delivery sheath 152 and delivery wire 156 in place.
- the distal side 30 of occluder 70 is deployed by withdrawing delivery wire 156 proximally to reduce the axial length between the central tube 22 and the distal tip 39 of occluder 70 , while holding delivery sheath 152 and delivery catheter 154 in place. Still referring to FIG.
- the proximal side 40 of occluder 70 is exposed by further withdrawing delivery sheath 152 proximally while holding delivery catheter 154 and delivery wire 156 in place.
- the proximal side 40 of occluder 70 is deployed by advancing delivery catheter 154 distally to reduce the axial length between the central tube 22 and the proximal tip 44 of occluder 70 , while holding delivery sheath 152 and delivery wire 156 in place.
- proximal side 40 of occluder 70 is deployed by withdrawing delivery wire 156 proximally to reduce the axial length between the central tube 22 and the proximal tip 44 of the occluder 70 , while holding delivery sheath 152 and delivery catheter 154 in place. Referring to FIG.
- occluder 70 is locked in its deployed configuration as the proximal tip 44 is advanced beyond arms 104 .
- arms 104 are partially activated, i.e. released into the temporary catch configuration illustrated in FIG. 11 , when surface 156 a of the delivery wire 156 collides with the distal surface 104 a of arms 104 .
- Occluder 70 is then released by unscrewing the threaded portion 153 of the delivery catheter 152 from the threaded portion 150 , and unscrewing the threaded portion 117 of the catch tube 102 from the delivery wire 156 . Withdrawal of delivery catheter 152 releases arms 104 into a permanent catch configuration illustrated in FIGS. 7-9 .
- FIG. 12A illustrates an alternative embodiment of the catch member after the delivery wire 156 has been unscrewed and withdrawn.
- the embodiment of the proximal catch member has straight arms 180 with tips 182 exerting force against the proximal edge 151 of the threaded portion 150 .
- the outer rim of the proximal edge touches tips 182 .
- FIG. 12B illustrates an alternative embodiment of the catch member after the delivery wire 156 has been unscrewed and withdrawn.
- the embodiment of the proximal catch member has V-shaped arms 200 with tips 202 restraining movement of the proximal surface 151 a of the proximal edge 151 of the occluder to prevent the occluder from expanding axially into its delivery configuration. While the embodiments of FIG. 12A and 12B are illustrated with the threaded portion 117 at the distal side of arms 104 , the threaded potion can also be located at the proximal side of arms 104 .
- FIG. 13 illustrates the initial step for a typical delivery sequence in accordance with one aspect of the disclosure.
- Occluder 224 and catch member 222 are secured to the delivery catheter 152 and to the delivery wire 156 , respectively.
- the threaded portion of the delivery catheter 153 is screwed onto the male threaded portion 150 of occluder 224 .
- the threaded portion of the delivery wire 156 is screwed onto the female threaded portion 117 of the catch member 222 .
- the male and female threads can be reversed if desired.
- the distal end of the delivery sheath 154 with the enclosed occluder 224 is inserted through the aperture to be occluded, such as the anatomical aperture 18 a or 18 b of FIG. 1 , to approximately the midpoint of the occluder 224 .
- the distal side 30 of occluder 224 is deployed on the distal side of the aperture in the left atrium 13 .
- the distal portion 30 is deployed by first retracting the delivery sheath 154 to expose the distal portion 30 of occluder 224 .
- Force F 2 is simultaneously applied to the delivery catheter 152 and delivery wire 156 to hold occluder 224 stationary.
- the axial length of occluder 224 is then reduced by applying pulling force F 1 on the delivery wire 156 with sufficient force to cause arms 104 of the catch member 222 to be pulled through the central tube 22 of occluder 224 and the distal portion 30 of occluder 224 to compress and the distal petals 32 to form.
- the central tube 22 of occluder 224 catches on the catch member 222 . This holds the distal petals 32 in place while the remainder of the deployment sequence is carried out.
- the proximal side 40 of occluder 224 is deployed on the proximal side of the aperture in the right atrium 11 .
- the proximal portion 40 is deployed by first retracting the delivery sheath 154 to expose the proximal portion 40 of occluder 224 .
- the proximal petals 42 are then formed by simultaneously advancing the delivery catheter 152 by applying force F 2 and retracting the delivery wire 156 by applying force F 1 to maintain the position of occluder 224 .
- the proximal tip 44 of occluder 224 is pushed over arms 104 of the catch member 222 and occluder 224 is caught on the distal surface 104 a of arms 104 .
- Occluder 224 can now be evaluated for proper deployment at the desired location, for example by fluoroscopy or any other suitable technique with the delivery system 220 , including delivery sheath 154 , delivery catheter 152 , and delivery wire 156 attached or partially detached.
- the delivery system 220 can be partially detached by releasing the securement system provided by the threaded connection to the proximal tip of the occluder.
- the delivery sheath 154 can be further retracted and the delivery catheter 152 can be detached from occluder 224 .
- the delivery catheter 152 can be detached by applying torque to unscrew the delivery catheter 152 from the proximal threaded portion 150 of occluder 224 and retracting the delivery catheter 152 .
- the delivery wire 156 continues to secure occluder 224 , as illustrated in FIG. 17 . This affords the clinician a substantially unobstructed view of the occluder delivery site in order to evaluate the placement of occluder 224 .
- the more flexible distal portions of the delivery catheter 152 and the delivery wire 156 allow the distal end of the delivery system 220 and the deployed occluder to be re-positioned so that the view is not obstructed.
- the positioning of occluder 224 can be evaluated using fluoroscopy or other appropriate techniques.
- the occluder can be retrieved or repositioned in the sequence shown in FIGS. 18-22 .
- delivery catheter 152 As illustrated in FIG. 18 , if delivery catheter 152 has been detached, it is reattached by advancing the threaded portion 153 of the delivery catheter 152 toward the threaded portion 150 of occluder 224 and applying torque until the delivery catheter 152 is threaded onto the threaded portion 150 of occluder 224 , as illustrated in FIG. 18 .
- the delivery sheath 154 is pushed towards occluder 224 . Then force F 3 is applied to the delivery catheter 152 to pull the proximal portion 40 of occluder 224 over the arms 104 of the catch member 222 .
- force F 3 is applied to the delivery catheter 152 to pull the proximal portion 40 of occluder 224 over the arms 104 of the catch member 222 .
- FIG. 20 as the delivery sheath 154 is advanced distally to cover the proximal portion 40 of occluder 224 , the axial length of occluder 224 is increased, the proximal petals 42 are unformed and the proximal portion 40 of occluder 224 returns to its tubular profile. Referring to FIG.
- force F 5 is applied to the delivery sheath 154 to advance it over the proximal portion 40 of occluder 224 and retain the proximal portion 40 of occluder 224 in the low-profile configuration.
- force F 6 is applied to the delivery wire 156 in order to release the distal portion 30 of occluder 224 and further increase the axial length of occluder 224 .
- the distal portion 30 of occluder 224 is fully extended back into its low-profile configuration and forces F 7 and F 8 are applied to the delivery sheath 154 and the delivery catheter 152 in order to retrieve occluder 224 back into delivery sheath 154 .
- FIG. 23 illustrates the detachment of the delivery wire 156 from the catch member 222 when an occluder is fully deployed and its position is satisfactory.
- the threaded portion of the delivery wire 156 is unscrewed from the threaded portion 117 of the catch member and the delivery wire 156 is then retracted into the delivery catheter 152 .
- the delivery wire 156 , the delivery catheter 152 and the delivery sheath 154 are then removed from the heart 10 by application of force F 9 .
- FIG. 24 illustrates an embodiment of the distal end of the catch member 222 , in which the distal tip 39 of the occluder is welded to the catch tube 102 using ultrasonic energy, heat, adhesive, or a solvent.
- both the catch member 222 and the catch tube 102 can be made of one piece.
- the threaded portion 117 may be disposed anywhere along the axis of the catch tube. In a preferred form, the threaded portion 117 may be immediately distal to arms 104 , not illustrated in FIG. 24 .
- FIGS. 25-28 illustrate exemplary steps in the manufacture of a catch member 300 by cutting a slit 303 into the proximal side 306 of the catch tube 302 to create a transverse, angled cut.
- the cut can be made at different angles with respect to the axis of the catch tube 302 . In a preferred form, the cut can be at approximately 45 degrees.
- Catch tube 302 is illustrated with a central lumen 312 and a threaded portion 317 at the distal side 308 of the tube. The threaded portion 317 may be at any location on the catch tube.
- a distal catch element is attached to the distal end 308 of the catch member via ultrasonic welding, heat welding, solvent bonding, or adhesive.
- the distal side 308 of the catch tube 302 is directly attached to the distal end 39 of the occluder via ultrasonic welding, heat welding, solvent bonding, or adhesive as shown, for example, in FIG. 24 .
- the proximal side 306 can be conditioned into a bent configuration, for example by annealing.
- An example of a step in this process is illustrated on FIG. 26 , where an annealing wire 316 is used to hold the proximal side 306 and the distal side 308 in a non-parallel configuration to create an opening 318 .
- FIG. 27 illustrates an exploded cross-sectional view of the catch member 300 in a bent configuration.
- FIG. 28 illustrates a view of the proximal side 306 along lines 28 - 28 in FIG. 27 , with the catching surface 304 a of the catching tip 304 a shown.
- FIGS. 29 and 30 illustrate steps of the deployment sequence of the occluder according to one embodiment of the disclosure.
- the threaded portion 153 of the delivery catheter 152 is connected with the threaded portion 150 of the proximal tip 44 of the occluder.
- the distal tip 39 of the occluder is threadably connected to the delivery wire 156 at the threaded portion 317 of the catch tube 302 .
- proximal side 306 and the distal side 308 of the catch tube 302 With the proximal side 306 and the distal side 308 of the catch tube 302 axially aligned and the delivery wire 156 held in place, delivery sheath 154 is withdrawn proximally to expose the distal side 30 of the occluder, delivery catheter 152 is pushed towards the distal tip 39 of the occluder to deploy the distal side 30 .
- the proximal side 40 of the occluder is exposed by further withdrawing delivery sheath 154 proximally while holding delivery catheter 152 and delivery wire 156 in place.
- the proximal side 40 of the occluder is deployed by advancing delivery catheter 152 distally.
- proximal side 40 of the occluder is deployed by withdrawing delivery wire 156 proximally.
- the occluder upon full deployment of the occluder and upon satisfaction with its position, the occluder is released by unscrewing the delivery catheter 152 from the threaded portion 150 of the occluder, next unscrewing the delivery wire 156 from the threaded portion 317 of the catch tube 302 , and finally withdrawing delivery catheter 152 , delivery sheath 154 , and delivery wire 156 proximally.
- the delivery wire 156 is unscrewed from the threaded portion 317 and withdrawn, the proximal side 306 of the catch tube 302 and the catching tip 304 are released into the bent configuration, which secures the occluder in the deployed configuration.
- FIG. 31 illustrates a deployed occluder after the delivery wire 156 has been detached from the occluder.
- surface 150 a rests against the proximal side of the catch tube 306 and/or the catching surface 304 a to maintain the occluder in a deployed configuration.
- FIGS. 32-35 Another embodiment of a catch member according to the disclosure is illustrated in FIGS. 32-35 .
- FIGS. 32 and 33 illustrate steps in the manufacture of the catch member 400 by cutting slits 403 into the proximal side 406 of the catch tube 402 .
- Catch tube 402 is illustrated with a central lumen 412 , a threaded portion 417 , a stopper element 414 and a distal catch element 410 .
- the distal catch element 410 is attached to the distal end 39 of the occluder via ultrasonic welding, heat welding, solvent bonding, or adhesive as shown.
- the distal side 408 of the catch tube 402 is directly attached to the distal end 39 of the occluder via ultrasonic welding, heat welding, solvent bonding, or adhesive as shown, for example, in FIG. 24 .
- the catch member 400 is conditioned to a deployed configuration by, for example, annealing with protrusions 404 formed. This can be done by applying forces F m to reduce the axial length of the catch tube 402 while annealing the catch tube 402 , which results in formation of protrusions 404 . While four protrusions are illustrated, more or fewer protrusions can be made and employed from the catch tube 402 .
- FIGS. 33-35 the catch member 400 is illustrated in a deployed configuration with protrusions 404 formed. In FIG. 32 , the catch member 400 is in its delivery configuration with no protrusions formed as shown.
- FIG. 34 illustrates a more detailed cross-sectional view of protrusions 404 and the stopper element 414 .
- the stopper element 414 is firmly attached to the tube 402 , and may contain one or more holes to connect the proximal lumen 412 a to the distal lumen 412 b .
- the stopper element is used to provide a stop for the delivery wire when being screwed in.
- FIG. 35 illustrates a view along lines 35 - 35 of FIG. 33 . While the number of protrusions 404 illustrated in FIGS. 33-35 is four, a number greater or lesser than four is also encompassed by this disclosure.
- FIGS. 36 and 37 illustrate steps of the deployment sequence of the occluder according to one embodiment of the disclosure.
- the threaded portion 153 of the delivery catheter 152 is connected to the threaded portion 150 of the proximal tip 44 of the occluder.
- the distal tip 39 of the occluder is threadably connected to the delivery wire 156 at the threaded portion 417 of the catch tube 402 .
- the catch member 400 is converted into a delivery configuration by screwing the delivery wire 156 into the threaded portion 417 . As the delivery wire travels toward the distal side 408 of the catch tube 402 , it hits the stopper element 414 .
- FIGS. 36 and 37 Further screwing elongates protrusions 404 and converts the catch member 400 into its delivery configuration, as illustrated in FIGS. 36 and 37 .
- the delivery sheath 154 is withdrawn proximally to expose the distal side 30 of the occluder and the delivery catheter 152 is pushed towards the distal tip 39 of the occluder to deploy the distal side 30 of the occluder.
- the proximal side 40 of the occluder is exposed by further withdrawing the delivery sheath 154 proximally, while holding the delivery catheter 152 and the delivery wire 156 in place.
- the proximal side 40 of the occluder is deployed by advancing the delivery catheter 152 distally.
- the proximal side 40 of the occluder is deployed by withdrawing the delivery wire 156 proximally.
- the occluder upon full deployment of the occluder and satisfaction with its position, the occluder is released by unscrewing the delivery catheter 152 from the threaded portion 150 of the occluder, then unscrewing the delivery wire 156 from the threaded portion 417 of the catch tube 402 , and finally withdrawing the delivery catheter 152 , delivery sheath 154 , and delivery wire 156 proximally. Once the delivery wire 156 is unscrewed from the threaded portion 417 and withdrawn, the catch member 400 is released into its deployed configuration with protrusions 404 formed.
- FIG. 39 illustrates the catch member 400 with protrusions 444 in the deployed configuration biased towards the distal side 408 of the catch tube 402 .
- This biasing can be achieved by modification of the manufacturing process, a step of which is illustrated in FIG. 33 .
- FIG. 40 illustrates the catch member 400 with protrusions 454 in the deployed configuration biased towards the proximal side 406 of the catch tube 402 .
- This biasing can be achieved by modification of the manufacturing process, a step of which is illustrated in FIG. 33 .
- annealing can be used to create alternate shapes.
- FIG. 41 illustrates yet another alternative embodiment of the catch member 400 .
- slits 463 are cut at an angle ⁇ with respect to the axis of the catch tube 402 .
- FIGS. 43A, 43B and 44 illustrate another embodiment of the invention.
- a catch system 600 includes a temporary and a permanent catch that are achieved by a bump 601 on the proximal portion of a catch system, for example a catch tube by the use of two threads of different pitches.
- bump 601 is formed on the proximal side of the tube by a material processing technique such as annealing.
- the use of two different pitches allows the catch member to be elongated in a delivery (reduced profile) configuration when a delivery wire is attached to the catch member. As the delivery wire is unscrewed from the catch member, the bump re-forms to provide a catch.
- FIG. 43A illustrates a cross-section of the proximal portion of the catch member during the deployment stage.
- the proximal end of the catch member, proximal to bump 601 rests on the proximal section of the delivery wire 604 .
- a proximal section 605 of the delivery wire 604 has a larger diameter than the distal section of the delivery wire 606 .
- the difference in diameters can be smaller or larger than the difference illustrated in FIGS. 43A, 43B and 44 .
- diameters of the proximal section of the delivery wire 604 and the distal section of the delivery wire 606 may be nearly identical.
- a delivery wire has a smaller diameter at its distal section 606 and a larger diameter at its proximal section 604 .
- the difference in diameters can be smaller or larger than the difference illustrated in FIGS. 43A, 43B , and 44 .
- the proximal side of the delivery wire 604 has a thread 614 and the distal side of the delivery wire 606 has a thread 616 .
- the proximal end 602 of the catch member 600 has a matching thread 612 to thread 614 of the same pitch.
- the distal end 603 of the catch member has a matching thread 613 to thread 616 of the same pitch. Thread 614 has a larger pitch than thread 616 , by at least 0.01 of an inch.
- the delivery wire 605 is advanced distally by threadably connecting threaded portion 613 of the delivery wire 605 and the threaded portion 616 of the catch member 600 , and threaded portion 614 of the delivery wire 605 and the threaded portion 612 of the catch member 600 . Because threaded portions 613 and 616 have a smaller pitch than threaded portions 612 and 614 , this results in the proximal end 602 advancing in the direction, indicated by arrow A relative to the delivery wire 605 , faster than the distal end 603 . Bump 601 of the catch member 600 is therefore elongated, and the catch member 600 is reduced to its delivery profile. The resultant configuration is illustrated in FIG. 43B .
- FIG. 43B illustrates the catch member in the delivery stage of the deployment process.
- bump 601 is reduced to a lower-profile configuration, allowing for a device, such as an occluder, to slide more easily over bump 601 .
- the catch member 600 could temporarily catch the occluder during its deployment with its proximal section of larger diameter. This may be useful during deployment, retrieval, repositioning or evaluation of deployment of an occluder. Once this is satisfactory, the delivery wire 605 can be removed by withdrawing it proximally.
- Removal of the delivery wire 605 results in the proximal end 602 moving in direction B faster than the distal end 603 , creating the high-profile configuration of bump 601 as illustrated in FIG. 44 .
- this may be desirable that this be accomplished in 1-10 turns, more preferably within 3-5 turns.
- suitable pitches include 0.011 inch pitch for threaded portion 613 of the catch member 600 and threaded portion 616 of the threaded wire 605 , and 0.030 inch pitch for threaded portion 612 of the catch member 600 and threaded portion 614 of the threaded wire 605 , or 0.011 inch pitch for threaded portion 613 of the catch member 600 and threaded portion 616 of the threaded wire 605 , and 0.025 inch pitch for threaded portion 612 of the catch member 600 and threaded portion 614 of the threaded wire 605 .
- FIG. 44 illustrates the catch member once the delivery wire has been detached and removed, creating a permanent catch for the occluder at its deployed configuration.
- proximal end 602 of the catch member 600 may constrict, for example at threads 612 , and create a permanent catch.
- the material may provide sufficient stability to allow the bump to maintain the device in the delivered configuration.
- Materials suitable for use with this embodiment include materials that are able to be easily deformed, for example metals, alloys, polymers, or combinations of these and similar materials.
- examples include, but are not limited to, bioabsorbable polymers such as polyhydroxyalkanoate compositions such as poly-4-hydroxybutyrate, bioabsorbable metals such as iron and magnesium.
- FIG. 45A illustrates a step in the manufacture of the catch member according to one aspect of the disclosure.
- Catch tube 502 is illustrated with lumen 503 , steps 510 , tabs 514 and lumens 505 , located at the proximal side 506 of the catch member.
- Tabs 514 and steps 510 can be made of the same piece of material as catch tube 502 , or they can be separate pieces made from the same, or different material.
- the vertical spacing between steps 510 is equal or slightly larger than the height of tabs 514 to allow tabs 514 to slide between steps 510 without leaving more than a minimal clearance between steps 510 and tabs 514 .
- Bump 504 (e.g. as shown in FIG. 45B ) can be created, for example by compressing the proximal and distal ends 506 and 508 , respectively, of the catch tube during annealing, similar to a scheme illustrated in FIG. 33 .
- FIG. 45B illustrates an embodiment of the catch member in a permanent catch configuration.
- Bump 504 has an outside diameter D 1 , which is larger than diameter of tube 502 .
- Alternate bump configurations including, but not limited to arms, barbs or other protrusions, are also encompassed by this disclosure.
- Tabs 514 are preformed, for example by annealing, into a curvilinear shape (although other suitable shapes also possible), such that when the catch member is not in contact with any other object (such as a delivery wire or an occluder), tabs 510 slide between steps 510 through lumen 505 , so that tab tips 515 protrude into lumen 503 .
- FIG. 45D is a view along lines 45 D- 45 D in FIG. 45B .
- FIG. 45F is a view along lines 45 F- 45 F in FIG. 45D .
- FIG. 45H is a view along lines 45 G- 45 G in FIG. 45D .
- FIG. 45H illustrates how tabs 514 prevent compression of the proximal side of the catch member 506 by sliding between steps 510 . Therefore, application of pressure on bump 504 does not result in a substantively compressed configuration, also referred to as the temporary catch configuration, illustrated in FIGS. 45C, 45E , 45 G and 45 I.
- a temporary catch configuration may be desired during deployment, retrieval, repositioning or evaluation of deployment of a device, such as an occluder.
- the proximal end of the catch member 506 can be compressed in a direction that reduces the volume of lumen 503 .
- the vertical dimension of lumens 505 is larger than the height of tabs 514 , to allow for compression of lumens 505 when tabs 514 (or tab tips 515 ) occupy lumens 505 as illustrated.
- This compressed configuration enables a device, or a portion of a device, such as a proximal portion of an occluder 520 with an inner diameter D 4 , to reversibly slide over bump 504 by exerting enough force on bump 504 to compress the proximal side 506 of the catch member.
- bump 504 has an outer diameter D 2 , which is smaller than diameter D 1 (illustrated in FIG. 45B ).
- a temporary catch configuration generally requires that the distal end of the delivery wire (not shown) occupies the distal portion of lumen 503 .
- FIG. 45E is a view along lines 45 E- 45 E in FIG. 45C , which further illustrates the temporary catch configuration.
- Delivery wire 516 is attached to the catch member and occupies a portion of lumen 503 .
- Tab tips 515 rub against the delivery wire 516 and are pushed out of lumen 503 as illustrated.
- the curvilinear shape of tabs 514 results in tabs 514 curving around the outside of steps 510 , allowing the proximal side of the catch member 506 to be compressed so that bump 504 has outside diameter D 2 .
- FIG. 45G which is a view along lines 45 G- 45 G in FIG. 45E .
- FIG. 45I illustrates how tabs 514 allow compression of the proximal side of the catch member 506 by being positioned outside of steps 510 . Therefore application of pressure on bump 504 will result in a compressed configuration.
- the catching configuration can be temporary or permanent.
- a temporary catch configuration generally allows for the catch member to release, while a permanent catch configuration generally is not designed for release.
- Certain embodiments have both a temporary catch configuration, which allows for confirmation of proper deployment, and a permanent catch configuration, that is engaged when proper deployment is confirmed.
- a permanent catch configuration can, for example, have a greater diameter at the proximal end of the catch member than a temporary catch configuration and may be engaged only after the device has been properly positioned.
- a temporary catch configuration is generally preferred during evaluation and repositioning of a device, such as an occluder, while a permanent catch configuration is generally preferred once the device is deployed.
- the embodiments and techniques described here are described preferably for use with a device made of a polymer and formed from a single tube, such that the tube is a single monolithic material.
- the catch mechanism can be all or partly monolithic or integral with the tubular structure, or there can be an absence of any type of bonding or rigid connection to the rest of the tubular structure, in which case there may be some spring force or other force that holds the locking mechanism in place. While the device is thus shown as being substantially formed from a single tubular body, the catch mechanism as described in the embodiments above could be used with other types of devices, including those formed from many pieces, and including devices formed from other materials, including metals, polymers, stainless steel or nitinol.
- bioabsorbable as used in the description above, is also understood to mean “bioresorbable.”
- wire might convey a more rigid piece than a string, a suture or a filament
- all these terms are essentially interchangeable, and further include embodiments in which the wire, string, suture or filament is a hollow tube or conduit to allow another wire, as needed, to pass through its longitudinal axis.
- Each wire, string, suture and filament can be composed of one or more wires, strings, sutures and filaments.
- the device is made of a polymer
- the sequence may be varied in certain respects, or the steps may be combined, while still obtaining the desired deployment or in some cases to effect deployment in a particular way.
- the delivery sheath may be advanced or retracted at varying times and in varying degrees, the proximal and distal portions of the occluder may be deployed into the petal configuration in a different sequence, etc.
- the steps could be automated.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This Application claims the benefit of priority to U.S. Provisional Application Ser. No. 60/753,681, filed Dec. 22, 2005, the disclosure of which is incorporated by reference herein.
- This invention relates generally to occlusion devices for the closure of physical anomalies, such as an atrial septal defect, a patent foramen ovale, and other septal and vascular defects. The invention also relates to mechanisms for deploying such devices and securing them in the deployed position.
- A patent foramen ovale (PFO), illustrated in
FIG. 1 , is a persistent, one-way, usually flap-like opening in the wall between theright atrium 11 and leftatrium 13 of theheart 10. Because left atrial (LA) pressure is normally higher than right atrial (RA) pressure, the flap usually stays closed. Under certain conditions, however, right atrial pressure can exceed left atrial pressure, creating the possibility that blood could pass from the right atrium 1 1 to theleft atrium 13 and blood clots could enter the systemic circulation. It is desirable that this circumstance be eliminated. - The foramen ovale serves a desired purpose when a fetus is gestating. Because blood is oxygenated through the umbilical cord, and not through the developing lungs, the circulatory system of the fetal heart allows the blood to flow through the foramen ovale as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two over-lapping layers of tissue: septum primum 14 and
septum secundum 16. However, a PFO has been shown to persist in a number of adults. - The presence of a PFO is generally considered to have no therapeutic consequence in otherwise healthy adults. Paradoxical embolism via a PFO is considered in the diagnosis for patients who have suffered a stroke or transient ischemic attack (TIA) in the presence of a PFO and without another identified cause of ischemic stroke. While there is currently no definitive proof of a cause-effect relationship, many studies have confirmed a strong association between the presence of a PFO and the risk for paradoxical embolism or stroke. In addition, there is significant evidence that patients with a PFO who have had a cerebral vascular event are at increased risk for future, recurrent cerebrovascular events.
- Accordingly, patients at such an increased risk are considered for prophylactic medical therapy to reduce the risk of a recurrent embolic event. These patients are commonly treated with oral anticoagulants, which potentially have adverse side effects, such as hemorrhaging, hematoma, and interactions with a variety of other drugs. The use of these drugs can alter a person's recovery and necessitate adjustments in a person's daily living pattern.
- In certain cases, such as when anticoagulation is contraindicated, surgery may be necessary or desirable to close a PFO. The surgery would typically include suturing a PFO closed by attaching septum secundum to septum primum. This sutured attachment can be accomplished using either an interrupted or a continuous stitch and is a common way a surgeon shuts a PFO under direct visualization.
- Umbrella devices and a variety of other similar mechanical closure devices, developed initially for percutaneous closure of atrial septal defects (ASDs), have been used in some instances to close PFOs. These devices potentially allow patients to avoid the side effects often associated with anticoagulation therapies and the risks of invasive surgery. However, umbrella devices and the like that are designed for ASDs are not optimally suited for use as PFO closure devices.
- Currently available septal closure devices present drawbacks, including technically complex implantation procedures. Additionally, there are significant complications due to thrombus, fractures of the components, conduction system disturbances, perforations of heart tissue, and residual leaks. Many devices have high septal profile and include large masses of foreign material, which may lead to unfavorable body adaptation of a device. Given that ASD devices are designed to occlude holes, many lack anatomic conformability to the flap-like anatomy of PFOs. Thus, when inserting an ASD device to close a PFO, the narrow opening and the thin flap may form impediments to proper deployment. Even if an occlusive seal is formed, the device may be deployed in the heart on an angle, leaving some components insecurely seated against the septum and, thereby, risking thrombus formation due to hemodynamic disturbances. Finally, some septal closure devices are complex to manufacture, which may result in inconsistent product performance.
- Various designs have disclosed septal closure devices made from a tube. These devices generally have a low septal profile in a delivery configuration, and a high septal profile in a deployed configuration. Upon deployment, these devices seal a septal defect. The unique design of these tube-made devices, however, requires an additional catch mechanism to catch the devices in their deployed configurations.
- Various catch member designs have been proposed to catch the tube-made septal closure devices in the deployed configuration, temporary and permanently. Making such catch members capable of forming a temporary lock during partial deployment and a more secure permanent lock after full deployment has proved challenging. Some designs are not sufficiently reliable and other designs cannot be manufactured effectively. Finally, some designs, while workable on paper, do not perform satisfactorily in the human body.
- The septal closure devices and techniques disclosed herein are designed to address these and other deficiencies of prior art design and techniques for delivering and retrieving such devices.
- In some aspects, the present invention includes several delivery devices and techniques for delivering an implant into a desired location within the body. This delivery technique relates particularly to, but is not limited to, a septal occluder made from a polymer tube. These delivery techniques, in addition to use with septal occluders, can be applied to other medical devices, such as other expandable devices constructed to be delivered in a reduced profile configuration to an expanded profile or delivered configuration.
- Catch members may be used to deploy and keep the device in place. According to some embodiments, the catch member maintains a reduced axial length of the device when the device is in the deployed configuration. Also, varied constructions could be used to maintain the axial dimension of the device, such as different locking mechanisms. Preferably, the catch member secures both sides of the device in the reduced profile configuration with a single element. Generally, during the delivery stage, the catch member has a smaller diameter at its proximal end compared to the diameter of the proximal end of the occluder. This configuration allows the proximal end of the occluder to slide over the proximal end of the catch member during deployment sequence. This may be achieved by compression of the proximal end of the catch member, by expansion of the proximal end of the occluder, or a combination of both. In a catching configuration, the catch member generally has a greater diameter at its proximal end compared to the diameter of the proximal end of the occluder, which keeps the occluder in its deployed configuration.
- In various embodiments, the catching configuration can be temporary or permanent. A temporary catch configuration generally allows for the catch member to release, while a permanent catch configuration generally is not designed for release. Some embodiments have a temporary catch configuration, which allows for confirmation of proper deployment, and a permanent catch configuration, that is engaged when proper deployment is confirmed.
- In certain embodiments, a permanent catch configuration can, for example, have a greater diameter at the proximal end of the catch member than a temporary catch configuration. A temporary catch configuration is generally preferred during evaluation and repositioning of a device, such as an occluder, while a permanent catch configuration is generally preferred once the device is deployed.
- According to at least some embodiments, the catch member is formed from a tube. According to some embodiments, the tube includes a material selected from the group consisting of metals, shape memory materials, alloys, polymers, bioabsorbable polymers, and combinations thereof. In particular embodiments, the tube includes a shape memory polymer. In particular embodiments, the tube includes nitinol. In some embodiments, the tube is formed by rolling a flat piece of material into a tubular form. According to some embodiments, the catch member is formed by cutting the tube. The catch member is placed in its deployment configuration by fixing the axial length of the device, for example by preventing the proximal end of the device from sliding over the proximal catch element.
- In some embodiments, the catch member uses a partially cut tube, with an axis of the proximal portion of the tube at an angle with respect to the axis of the distal side of the tube. A portion of the proximal side of the tube catches the proximal end of the device and keeps it in a deployed position.
- In some embodiments, the catch member uses a series of protrusions at its proximal end. Once the protrusions are released, for example by removing the delivery wire, the protrusions project radially outward from the proximal side of the tube and keep the device in its locked position by preventing the proximal end of the device from sliding over the protrusions. In various embodiments, the protrusions are biased towards the proximal or the distal end of the catch member. In some embodiments, they may be twisted relative to the axis of the catch member.
- In certain embodiments, the catch member may include a bump and pre-curved tabs at its proximal side. The bump is interrupted by a largely planar lumen slicing through the proximal side of the catch member. The lumen allows compression of the catch member with the delivery wire attached to provide a temporary catch configuration. In some embodiments, after the delivery wire is removed, the tabs automatically slide into the lumen to prevent or reduce compressibility of the catch member, thus providing a permanent catch configuration.
- In a further aspect, the catch member may include a delivery wire and a catch tube that is threadedly secured to the delivery wire at two different locations. Each threaded connection has different pitches. Twisting of the delivery wire with respect to the catch tube creates a temporary or permanent catch depending on the selected design criteria. This system is especially adapted to construction with malleable materials. In another aspect, the protrusions can be threaded with different pitches to allow for modulation of the protrusion configuration by twisting the delivery wire.
- These and other aspects and embodiments of the disclosure are illustrated and described below.
- In the Drawings:
-
FIG. 1 is a schematic representation of a human heart including various septal defects; -
FIG. 2 shows an occluder and a catch member according to one embodiment of the disclosure; -
FIG. 3 illustrates an occluder and a catch member during the initial stage of deployment according to one embodiment of the invention; -
FIG. 4 illustrates an occluder and a catch member with the distal side of the occluder in its deployed configuration according to one embodiment of the invention; -
FIG. 5 illustrates an occluder and a catch member in a deployed configuration according to one embodiment of the invention; -
FIG. 6 is a view of cuts made during manufacture of a catch member according to one embodiment of the invention; -
FIG. 7 is a view of a catch member according to one embodiment of the invention; -
FIG. 8 is a cross-sectional view of the catch member along lines 8-8 inFIG. 7 according to one embodiment of the invention; -
FIG. 9 is an exploded cross-sectional side view of the catch member along lines 9-9 inFIG. 8 according to one embodiment of the invention; -
FIG. 10 is a cross-sectional side view of one step in a deployment sequence according to one embodiment of the invention; -
FIG. 11 is a cross-sectional side view of one step in a deployment sequence according to one embodiment of the invention; -
FIG. 12A is a cross-sectional side view of a deployed occluder and a catch member according to one embodiment of the invention; -
FIG. 12B is a cross-sectional side view of a deployed occluder and a catch member according to one embodiment of the invention; -
FIG. 13 is an axial cross-sectional drawing of an occluder and a catch member, in a delivery configuration, according to one embodiment of the invention; -
FIGS. 14-17 are cross-sectional side views of various steps in a deployment sequence according to one embodiment of the invention; -
FIGS. 18-22 are cross-sectional side views of various steps in a retrieval sequence according to one embodiment of the invention; -
FIG. 23 is a cross-sectional side view of a detachment step according to one embodiment of the invention; -
FIG. 24 is an exploded view of an embodiment of the distal portion of the catch member according to one aspect of the invention; -
FIG. 25 is a view of the cut(s) made during the manufacture of a catch member according to one embodiment of the invention; -
FIG. 26 is a cross-sectional view of a step in the manufacture of the catch member according to one embodiment of the invention; -
FIG. 27 is an exploded cross-sectional view of the catch member according to one embodiment of the invention; -
FIG. 28 is an exploded cross-sectional side view of the catch member along lines 28-28 inFIG. 27 according to one embodiment of the invention; -
FIGS. 29-30 are cross-sectional side views of various steps in the deployment sequence according to one embodiment of the invention; -
FIG. 31 is a cross-sectional side view of the delivery system during the detachment process according to one embodiment of the invention; -
FIG. 32 is a view of cuts made during manufacture of a catch member according to one embodiment of the invention; -
FIG. 33 is a view of a step in the manufacture of a catch member according to one embodiment of the invention; -
FIG. 34 is an expanded cross-sectional side view of the catch member according to one embodiment of the invention; -
FIG. 35 is an exploded cross-sectional side view of the catch member along lines 35-35 inFIG. 34 according to one embodiment of the invention; -
FIGS. 36-37 are cross-sectional side views of various steps in the deployment sequence according to one embodiment of the invention; -
FIG. 38 is a cross-sectional side view of the delivery system during the detachment process according to one embodiment of the invention; -
FIG. 39 is a view of a catch member according to one embodiment of the invention; -
FIG. 40 is a view of a catch member according to one embodiment of the invention; -
FIG. 41 is a view of cuts made during manufacture of a catch member according to one embodiment of the invention; -
FIG. 42 is a view of a catch member according to one embodiment of the invention; -
FIG. 43A illustrates an embodiment of the proximal catch element in a starting configuration according to one aspect of the invention; -
FIG. 43B illustrates an embodiment of the proximal catch element in a temporary catch configuration according to one aspect of the invention; -
FIG. 44 illustrates an embodiment of the proximal catch element in a permanent catch configuration according to one aspect of the invention; -
FIG. 45A illustrates a step in the manufacture of the catch member according to one embodiment of the invention; -
FIGS. 45B, 45D , 45F and 45H illustrate an embodiment of the catch member in a permanent catch configuration according to one aspect of the invention; and -
FIGS. 45C, 45E , 45G and 45I illustrate an embodiment of the catch member in a temporary catch configuration according to one aspect of the invention. - Aspects of the present invention provide devices, delivery/retrieval systems and techniques for delivering such devices intended to occlude an aperture within body tissue. In particular, and as described in detail below, the described occluder may be used for closing an ASD, VSD or PFO in the atrial septum of a heart. Although the embodiments are described with reference to an ASD, VSD or PFO, one skilled in the art will recognize that the device and methods of the present invention may be used to treat other anatomical conditions. As such, the invention should not be considered limited in applicability to any particular anatomical condition. In addition, the systems and methods for delivery and retrieval, and for catching a device in a deployed state, that are aspects of the present invention may also be used in connection with other types of devices besides an occluder, in particular, devices having tubular profiles.
-
FIG. 1 illustrates ahuman heart 10, having aright atrium 11 and aleft atrium 13 and including variousanatomical apertures 18 a and 18 b. Theatrial septum 12 includes septum primum 14 andseptum secundum 16. The anatomy of theseptum 12 varies widely within the population. In some people, septum primum 14 extends to and overlaps withseptum secundum 16. The septum primum 14 may be quite thin. When the anatomical apertures 18 a is present, blood could travel through the anatomical aperture 18 a between septum primum 14 and septum secundum 16 (referred to as “the PFO tunnel”). Additionally, or alternatively, the presence of an ASD could permit blood to travel through an aperture in the septal tissue, such as through theanatomical aperture 18 b. - this application, “distal” refers to the direction away from a catheter insertion location and “proximal” refers to the direction nearer the insertion location. Additionally, the term “delivery configuration” refers to the configuration of a device, such as an occluder, when it has a reduced profile in a delivery sheath or catheter. The term “deployed configuration” refers to the configuration of the device, such as an occluder, when it has deployed from the catheter, such as at the desired implantation location.
-
FIGS. 2-5 illustrate an exemplary occluder with which systems and techniques disclosed herein may be used. Acatch member 50 contains aproximal catch element 52 and a distal catch element, such as aflange 54, and is designed to be disposed at the distal end oftube 25 ofoccluder 70.Occluder 70, for example, can be formed by cutting a series of slits ontube 25. As shown inFIGS. 3-5 ,distal petals 32 are produced by cuttingslits 31 in the upper portion oftube 25 according to the cutting pattern shown inFIG. 2 . As shown inFIG. 3 , the distal portion of thetube 25 is cut in half to formhalf sections half sections distal tip 39 intoquarter sections quarter sections distal tip 39, andquarter sections form half section 94 b atdistal tip 39. Upon application of force Fd todistal tip 39, struts defined byslits 31 bow and twist outward to formdistal petals 32 indistal side 30, as shown inFIGS. 4-5 . The movement of the struts during deployment is such that the struts rotate in an orthogonal plane relative to the axis of the device.Central tube 22 may be constrained during the application of force Fd, or any combination of forces sufficient to reduce the axial length of thetube 25 may be applied. One end of each ofdistal petals 32 originates fromcentral tube 22, while the other end originates from distal tip 39 (FIGS. 3-4 ).Proximal petals 42 may be formed inproximal side 40, as shown inFIGS. 3-5 , makingslits 41 betweencentral tube 22 andproximal tip 44, using the same cutting pattern described above. - The tube(s) 25 forming
occluder 70 may be formed from a biocompatible metal or polymer. In at least some embodiments,occluder 70 is formed of a bioabsorbable polymer, or a shape memory polymer. Shape memory polymers can be advantageous so that the structure of the device assists in pressing the PFO tunnel closed. In other embodiments,occluder 70 is formed of a biocompatible metal, such as a shape memory alloy (e.g., nitinol). The thermal shape memory and/or superelastic properties of shape memory polymers and alloys permitoccluder 70 to resume and maintain its intended shape in vivo despite being distorted during the delivery process. Alternatively, or additionally,occluder 70 may be formed of a bioabsorbable metal, such as iron, magnesium, or combinations of these and similar materials. Exemplary bioabsorbable polymers include polyhydroxyalkanoate compositions, for example poly-4-hydroxybutyrate (P4HB) compositions, disclosed in U.S. Pat. No. 6,610,764, entitled Polyhydroxyalkanoate Compositions Having Controlled Degradation Rate and U.S. Pat. No. 6,548,569, entitled Medical Devices and Applications of polyhydroxyalkanoate Polymers, both of which are incorporated by reference in their entirety. - The cross-sectional shape of
tube 25 may be circular or polygonal, for example square, pr hexagonal. Theslits - The tube can be injection molded, extruded, or constructed of a sheet of material and rolled into a tube. The sheet of material could be a single ply sheet or multiple ply. The slits that form the struts could be cut or stamped into the sheet prior to rolling the sheet into a tube to connect the ends to form an enclosed cross section. Various geometrical cross sections are possible including circular, square, hexagonal and octagonal and the joint could be at the vertex or along the flat of a wall if the cross section is of a particular geometry. Various attachment techniques could be used to join the ends of the sheet to form a tube, including welding, heat adhesives, non-heat adhesives and other joining techniques suitable for in-vivo application.
- The petal configuration is the deployed configuration.
Occluder 70 can be secured in the petal configuration by a catch member that holds the ends of thetube 25 together, certain embodiments of which are described below. Use of the terms distal and proximal sides orportions - The embodiment described in conjunction with
FIGS. 2-5 has similarities to the devices disclosed in U.S. patent application Ser. No. 10/890,784, entitled Tubular Patent Foramen Ovale (PFO) Closure Device with Locking Mechanism, filed on Jul. 14, 2004; U.S. patent application Ser. No. 11/070,027, entitled Delivery/Recovery System for Clover Leaf Septal Occluder, filed on Mar. 2, 2005; U.S. patent application Ser. No. 11/235,661, entitled Occluder Device Double Securement System for Delivery/Recovery of Such Occluder Device, filed Sep. 16, 2005; U.S. patent application Ser. No. 11/384,635, filed Mar. 20, 2006, entitled Catch Member for PFO Occluder; U.S. patent application Ser. No. 60/662,990, filed Mar. 18, 2004, entitled Suture Delivery/Recovery System for PFO Occluder with Catch System; and U.S. patent application Ser. No. 11/395,718, entitled Tubular Patent Foramen Ovale (PFO) Closure Device with Catch System, filed Mar. 31, 2006; all of which have the same assignee as the present application, and are incorporated by reference in their entirety. These incorporated documents describe how a device can be formed by making cuts or slits in a tube and compressing the ends, and how to deliver such a device. Embodiments of the catch members described herein are not restricted to the particular embodiment of occluder shown inFIGS. 2-5 and may be used with a number of devices and, in particular, may be used in conjunction with various devices described in the aforementioned patent applications. - In one alternate embodiment of an occluder, one end of each of distal petals originates from a central tube, while the other end originates from the distal end. Upon application of a force to the distal end to reduce the axial length, extended segments defined by slits in the tube bow and twist outward to form the distal petals in the distal side of the occluder. The movement of the segments during deployment is such that the segments rotate in an orthogonal plane relative to the axis of the device. The central tube may be constrained during the application of force, or any combination of forces sufficient to reduce the axial length of the tube may be applied. This embodiment is illustrated, for example, in
FIGS. 2E-2H of U.S. patent application Ser. No. 11/395,718, which has been incorporated by reference above. - The transformable design of
occluder 70 enablesoccluder 70 to be delivered in a low profile, tubular form and to be converted readily, i.e., by reducing the axial length, in place to the high-profile deployed configuration. Moreover, the conversion can readily be effected by forcingdistal tip 39 andproximal tip 44 together. For example,distal side 30 andproximal side 40 ofoccluder 70 may be deployed in separate steps, or bothdistal side 30 andproximal side 40 ofoccluder 70 may be exposed (e.g., out of the delivery catheter) prior to engaging the catch member and deployed together as the catch member is engaged. -
Occluder 70 may be prepared for delivery to anaperture 18 a or 18 b in any one of several ways.Slits tube 25 bends into its intended configuration following deployment in vivo. Specifically, slits 31 and 41 may be cut to producestruts loops FIGS. 3 and 4 . Alternatively and/or additionally, atube 25 formed of a shape memory material may be preformed into its intended configuration ex vivo so that it will recover its preformed shape once deployed in vivo. According to at least some embodiments, this preforming technique produces more reliable deployment and bending ofoccluder 70 in vivo. An intermediate approach may also be used:tube 25 may be only slightly preformed ex vivo such that it is predisposed to bend into its intended shape in vivo upon application of forces Fd and Fp. - An embodiment of the catch member according to one aspect of the invention is illustrated in
FIGS. 6-9 .FIGS. 6 and 7 illustrate aspects of the manufacture of thecatch member 100. Specifically, slits 103 (which include atransverse slit 103 a andaxial slits 103 b) are cut into theproximal side 106 of thecatch tube 102 to createarms 104, each arm having adistal surface 104 a. Twoarms 104 are illustrated. Of course, any number greater than one is possible. The geometrical constraints of the tube and manufacturing constraints of the slits would allow for up to 8 arms.Catch tube 102 is illustrated with a threadedportion 117, which is used to secure the delivery wire to the catch member, acentral lumen 112 into which the delivery wire is adapted to go and adistal catch element 110 at thedistal side 108 of the tube that serves to hold the distal end of the catch member to the occluder. The threadedportion 117 can be located at theproximal side 106 or thedistal side 108 of thecatch tube 102. By pushingarms 104 towards theproximal side 106 of the tube,arms 104 can be conditioned into a bent configuration as illustrated onFIG. 7 .FIG. 8 illustrates the axial view of thearms 104 along lines 8-8 inFIG. 7 . The conditioning process may include and can be enhanced by an annealing process, which can provide additional shape stability to thearms 104. After the conditioning process,arms 104 expand beyond the outside diameter of thecatch tube 102. An expanded cross-sectional view ofarms 104 in the bent configuration along lines 9-9 inFIG. 8 is shown inFIG. 9 .FIG. 9 illustratesrecess 118 created by the conditioning ofarms 104 into the bent configuration. The arms can also be called “tabs”, “stays”, “holders”, or any other suitable word or phrase. Referring toFIGS. 2-5 , thedistal side 108 of the catch tube may be ultrasonically welded tooccluder 70, or some other fixing agent, such as glue, can be used. Also referring toFIGS. 2-5 , thecatch tube 102 is slidably disposed within thecentral tube 22 ofoccluder 70, and therefore,central tube 22 is able to slide against thecatch tube 102 during the deployment and retrieval ofoccluder 70. -
FIGS. 10 and 11 illustrate steps in the deployment of the catching mechanism according to one embodiment of the disclosure.Occluder 70 is introduced to anaperture 18 a or 18 b by adelivery sheath 154 in its delivery configuration. Thedelivery catheter 152 is positioned within thedelivery sheath 154 with minimal clearance between them. The distal end of thedelivery catheter 152 includes a threadedportion 153. In one embodiment, the threadedportion 153 is connected with the threadedportion 150 of theproximal tip 44 of the occluder. Thedistal tip 39 of the occluder is threadably connected to thedelivery wire 156 at the threadedportion 117 of thecatch tube 102. As shown inFIG. 10 , the delivery wire has arecess 157, illustrated as a narrowing in the circumference, into which thearms 104 are rested, in unlocked position, during the delivery process. Therecess 157 can vary in size and in some designs may be optional. As discussed above, the threadedportion 117 can be located at theproximal side 106 or at thedistal side 108 of thecatch tube 102. - Referring to
FIG. 10 , thedistal side 30 ofoccluder 70 is exposed by withdrawingdelivery sheath 152 proximally while holdingdelivery catheter 154 anddelivery wire 156 stable. Thedistal side 30 ofoccluder 70 is deployed by advancingdelivery catheter 154 distally to reduce the axial length between thecentral tube 22 and thedistal tip 39 ofoccluder 70, while holdingdelivery sheath 152 anddelivery wire 156 in place. Alternatively, thedistal side 30 ofoccluder 70 is deployed by withdrawingdelivery wire 156 proximally to reduce the axial length between thecentral tube 22 and thedistal tip 39 ofoccluder 70, while holdingdelivery sheath 152 anddelivery catheter 154 in place. Still referring toFIG. 10 , theproximal side 40 ofoccluder 70 is exposed by further withdrawingdelivery sheath 152 proximally while holdingdelivery catheter 154 anddelivery wire 156 in place. Theproximal side 40 ofoccluder 70 is deployed by advancingdelivery catheter 154 distally to reduce the axial length between thecentral tube 22 and theproximal tip 44 ofoccluder 70, while holdingdelivery sheath 152 anddelivery wire 156 in place. Alternatively,proximal side 40 ofoccluder 70 is deployed by withdrawingdelivery wire 156 proximally to reduce the axial length between thecentral tube 22 and theproximal tip 44 of theoccluder 70, while holdingdelivery sheath 152 anddelivery catheter 154 in place. Referring toFIG. 11 ,occluder 70 is locked in its deployed configuration as theproximal tip 44 is advanced beyondarms 104. In this embodiment,arms 104 are partially activated, i.e. released into the temporary catch configuration illustrated inFIG. 11 , whensurface 156 a of thedelivery wire 156 collides with thedistal surface 104 a ofarms 104.Occluder 70 is then released by unscrewing the threadedportion 153 of thedelivery catheter 152 from the threadedportion 150, and unscrewing the threadedportion 117 of thecatch tube 102 from thedelivery wire 156. Withdrawal ofdelivery catheter 152releases arms 104 into a permanent catch configuration illustrated inFIGS. 7-9 . -
FIG. 12A illustrates an alternative embodiment of the catch member after thedelivery wire 156 has been unscrewed and withdrawn. InFIG. 12A , the embodiment of the proximal catch member hasstraight arms 180 withtips 182 exerting force against theproximal edge 151 of the threadedportion 150. As illustrated, the outer rim of the proximal edge touchestips 182. -
FIG. 12B illustrates an alternative embodiment of the catch member after thedelivery wire 156 has been unscrewed and withdrawn. InFIG. 12B , the embodiment of the proximal catch member has V-shapedarms 200 withtips 202 restraining movement of theproximal surface 151 a of theproximal edge 151 of the occluder to prevent the occluder from expanding axially into its delivery configuration. While the embodiments ofFIG. 12A and 12B are illustrated with the threadedportion 117 at the distal side ofarms 104, the threaded potion can also be located at the proximal side ofarms 104. -
FIG. 13 illustrates the initial step for a typical delivery sequence in accordance with one aspect of the disclosure.Occluder 224 and catchmember 222 are secured to thedelivery catheter 152 and to thedelivery wire 156, respectively. The threaded portion of thedelivery catheter 153 is screwed onto the male threadedportion 150 ofoccluder 224. The threaded portion of thedelivery wire 156 is screwed onto the female threadedportion 117 of thecatch member 222. Of course, the male and female threads can be reversed if desired. The distal end of thedelivery sheath 154 with theenclosed occluder 224 is inserted through the aperture to be occluded, such as theanatomical aperture 18 a or 18 b ofFIG. 1 , to approximately the midpoint of theoccluder 224. - Referring now to
FIG. 14 , thedistal side 30 ofoccluder 224 is deployed on the distal side of the aperture in theleft atrium 13. Thedistal portion 30 is deployed by first retracting thedelivery sheath 154 to expose thedistal portion 30 ofoccluder 224. Force F2 is simultaneously applied to thedelivery catheter 152 anddelivery wire 156 to holdoccluder 224 stationary. Referring now toFIG. 15 , the axial length ofoccluder 224 is then reduced by applying pulling force F1 on thedelivery wire 156 with sufficient force to causearms 104 of thecatch member 222 to be pulled through thecentral tube 22 ofoccluder 224 and thedistal portion 30 ofoccluder 224 to compress and thedistal petals 32 to form. Thecentral tube 22 ofoccluder 224 catches on thecatch member 222. This holds thedistal petals 32 in place while the remainder of the deployment sequence is carried out. - Referring now to
FIG. 16 , theproximal side 40 ofoccluder 224 is deployed on the proximal side of the aperture in theright atrium 11. Theproximal portion 40 is deployed by first retracting thedelivery sheath 154 to expose theproximal portion 40 ofoccluder 224. Theproximal petals 42 are then formed by simultaneously advancing thedelivery catheter 152 by applying force F2 and retracting thedelivery wire 156 by applying force F1 to maintain the position ofoccluder 224. Eventually, theproximal tip 44 ofoccluder 224 is pushed overarms 104 of thecatch member 222 andoccluder 224 is caught on thedistal surface 104 a ofarms 104. After thedelivery catheter 152 is detached fromoccluder 224, the resulting configuration is illustrated inFIG. 17 -
Occluder 224 can now be evaluated for proper deployment at the desired location, for example by fluoroscopy or any other suitable technique with thedelivery system 220, includingdelivery sheath 154,delivery catheter 152, anddelivery wire 156 attached or partially detached. Thedelivery system 220 can be partially detached by releasing the securement system provided by the threaded connection to the proximal tip of the occluder. As shown inFIG. 17 , according to one preferred embodiment, to evaluate the proper deployment of the occluder, if desired, thedelivery sheath 154 can be further retracted and thedelivery catheter 152 can be detached fromoccluder 224. Thedelivery catheter 152 can be detached by applying torque to unscrew thedelivery catheter 152 from the proximal threadedportion 150 ofoccluder 224 and retracting thedelivery catheter 152. Thedelivery wire 156 continues to secureoccluder 224, as illustrated inFIG. 17 . This affords the clinician a substantially unobstructed view of the occluder delivery site in order to evaluate the placement ofoccluder 224. In addition, the more flexible distal portions of thedelivery catheter 152 and thedelivery wire 156 allow the distal end of thedelivery system 220 and the deployed occluder to be re-positioned so that the view is not obstructed. The positioning ofoccluder 224 can be evaluated using fluoroscopy or other appropriate techniques. - If the delivery or deployment is not satisfactory, while the
delivery wire 156 continues to secureoccluder 224, then the occluder can be retrieved or repositioned in the sequence shown inFIGS. 18-22 . - As illustrated in
FIG. 18 , ifdelivery catheter 152 has been detached, it is reattached by advancing the threadedportion 153 of thedelivery catheter 152 toward the threadedportion 150 ofoccluder 224 and applying torque until thedelivery catheter 152 is threaded onto the threadedportion 150 ofoccluder 224, as illustrated inFIG. 18 . - Referring now to
FIG. 19 , thedelivery sheath 154 is pushed towardsoccluder 224. Then force F3 is applied to thedelivery catheter 152 to pull theproximal portion 40 ofoccluder 224 over thearms 104 of thecatch member 222. Referring toFIG. 20 , as thedelivery sheath 154 is advanced distally to cover theproximal portion 40 ofoccluder 224, the axial length ofoccluder 224 is increased, theproximal petals 42 are unformed and theproximal portion 40 ofoccluder 224 returns to its tubular profile. Referring toFIG. 21 , force F5 is applied to thedelivery sheath 154 to advance it over theproximal portion 40 ofoccluder 224 and retain theproximal portion 40 ofoccluder 224 in the low-profile configuration. Also, force F6 is applied to thedelivery wire 156 in order to release thedistal portion 30 ofoccluder 224 and further increase the axial length ofoccluder 224. - Referring now to
FIG. 22 , thedistal portion 30 ofoccluder 224 is fully extended back into its low-profile configuration and forces F7 and F8 are applied to thedelivery sheath 154 and thedelivery catheter 152 in order to retrieveoccluder 224 back intodelivery sheath 154. -
FIG. 23 illustrates the detachment of thedelivery wire 156 from thecatch member 222 when an occluder is fully deployed and its position is satisfactory. The threaded portion of thedelivery wire 156 is unscrewed from the threadedportion 117 of the catch member and thedelivery wire 156 is then retracted into thedelivery catheter 152. Thedelivery wire 156, thedelivery catheter 152 and thedelivery sheath 154 are then removed from theheart 10 by application of force F9. -
FIG. 24 illustrates an embodiment of the distal end of thecatch member 222, in which thedistal tip 39 of the occluder is welded to thecatch tube 102 using ultrasonic energy, heat, adhesive, or a solvent. Alternatively, both thecatch member 222 and thecatch tube 102 can be made of one piece. The threadedportion 117 may be disposed anywhere along the axis of the catch tube. In a preferred form, the threadedportion 117 may be immediately distal toarms 104, not illustrated inFIG. 24 . - Another embodiment of the catch member according to the disclosure is illustrated in
FIGS. 25-28 .FIGS. 25 and 26 illustrate exemplary steps in the manufacture of acatch member 300 by cutting aslit 303 into theproximal side 306 of thecatch tube 302 to create a transverse, angled cut. The cut can be made at different angles with respect to the axis of thecatch tube 302. In a preferred form, the cut can be at approximately 45 degrees.Catch tube 302 is illustrated with acentral lumen 312 and a threadedportion 317 at thedistal side 308 of the tube. The threadedportion 317 may be at any location on the catch tube. In one embodiment, a distal catch element is attached to thedistal end 308 of the catch member via ultrasonic welding, heat welding, solvent bonding, or adhesive. In another embodiment, thedistal side 308 of thecatch tube 302 is directly attached to thedistal end 39 of the occluder via ultrasonic welding, heat welding, solvent bonding, or adhesive as shown, for example, inFIG. 24 . - By conditioning the axis of the
proximal side 306 to be at an angle, for example at a right angle, with respect to the axis of thedistal side 308, theproximal side 306 can be conditioned into a bent configuration, for example by annealing. An example of a step in this process is illustrated onFIG. 26 , where an annealing wire 316 is used to hold theproximal side 306 and thedistal side 308 in a non-parallel configuration to create anopening 318.FIG. 27 illustrates an exploded cross-sectional view of thecatch member 300 in a bent configuration. The axes of theproximal side 306 anddistal side 308 of thecatch tube 302 are shown at approximately a right angle, although smaller and larger angles are also encompassed by this disclosure.FIG. 28 illustrates a view of theproximal side 306 along lines 28-28 inFIG. 27 , with the catchingsurface 304 a of the catchingtip 304 a shown. -
FIGS. 29 and 30 illustrate steps of the deployment sequence of the occluder according to one embodiment of the disclosure. Referring toFIG. 29 , in one embodiment, the threadedportion 153 of thedelivery catheter 152 is connected with the threadedportion 150 of theproximal tip 44 of the occluder. Thedistal tip 39 of the occluder is threadably connected to thedelivery wire 156 at the threadedportion 317 of thecatch tube 302. With theproximal side 306 and thedistal side 308 of thecatch tube 302 axially aligned and thedelivery wire 156 held in place,delivery sheath 154 is withdrawn proximally to expose thedistal side 30 of the occluder,delivery catheter 152 is pushed towards thedistal tip 39 of the occluder to deploy thedistal side 30. Referring now toFIG. 30 , theproximal side 40 of the occluder is exposed by further withdrawingdelivery sheath 154 proximally while holdingdelivery catheter 152 anddelivery wire 156 in place. Theproximal side 40 of the occluder is deployed by advancingdelivery catheter 152 distally. Alternatively,proximal side 40 of the occluder is deployed by withdrawingdelivery wire 156 proximally. - Referring to
FIG. 31 , upon full deployment of the occluder and upon satisfaction with its position, the occluder is released by unscrewing thedelivery catheter 152 from the threadedportion 150 of the occluder, next unscrewing thedelivery wire 156 from the threadedportion 317 of thecatch tube 302, and finally withdrawingdelivery catheter 152,delivery sheath 154, anddelivery wire 156 proximally. Once thedelivery wire 156 is unscrewed from the threadedportion 317 and withdrawn, theproximal side 306 of thecatch tube 302 and the catchingtip 304 are released into the bent configuration, which secures the occluder in the deployed configuration. -
FIG. 31 illustrates a deployed occluder after thedelivery wire 156 has been detached from the occluder. In this embodiment,surface 150 a rests against the proximal side of thecatch tube 306 and/or the catchingsurface 304 a to maintain the occluder in a deployed configuration. - Another embodiment of a catch member according to the disclosure is illustrated in
FIGS. 32-35 .FIGS. 32 and 33 illustrate steps in the manufacture of thecatch member 400 by cuttingslits 403 into theproximal side 406 of thecatch tube 402.Catch tube 402 is illustrated with acentral lumen 412, a threadedportion 417, astopper element 414 and adistal catch element 410. In one embodiment, thedistal catch element 410 is attached to thedistal end 39 of the occluder via ultrasonic welding, heat welding, solvent bonding, or adhesive as shown. In another embodiment, thedistal side 408 of thecatch tube 402 is directly attached to thedistal end 39 of the occluder via ultrasonic welding, heat welding, solvent bonding, or adhesive as shown, for example, inFIG. 24 . As illustrated inFIG. 33 , thecatch member 400 is conditioned to a deployed configuration by, for example, annealing withprotrusions 404 formed. This can be done by applying forces Fm to reduce the axial length of thecatch tube 402 while annealing thecatch tube 402, which results in formation ofprotrusions 404. While four protrusions are illustrated, more or fewer protrusions can be made and employed from thecatch tube 402. InFIGS. 33-35 , thecatch member 400 is illustrated in a deployed configuration withprotrusions 404 formed. InFIG. 32 , thecatch member 400 is in its delivery configuration with no protrusions formed as shown. -
FIG. 34 illustrates a more detailed cross-sectional view ofprotrusions 404 and thestopper element 414. Thestopper element 414 is firmly attached to thetube 402, and may contain one or more holes to connect the proximal lumen 412 a to thedistal lumen 412 b. The stopper element is used to provide a stop for the delivery wire when being screwed in.FIG. 35 illustrates a view along lines 35-35 ofFIG. 33 . While the number ofprotrusions 404 illustrated inFIGS. 33-35 is four, a number greater or lesser than four is also encompassed by this disclosure. -
FIGS. 36 and 37 illustrate steps of the deployment sequence of the occluder according to one embodiment of the disclosure. Referring toFIG. 36 , the threadedportion 153 of thedelivery catheter 152 is connected to the threadedportion 150 of theproximal tip 44 of the occluder. Thedistal tip 39 of the occluder is threadably connected to thedelivery wire 156 at the threadedportion 417 of thecatch tube 402. Thecatch member 400 is converted into a delivery configuration by screwing thedelivery wire 156 into the threadedportion 417. As the delivery wire travels toward thedistal side 408 of thecatch tube 402, it hits thestopper element 414. Further screwing elongatesprotrusions 404 and converts thecatch member 400 into its delivery configuration, as illustrated inFIGS. 36 and 37 . Referring toFIG. 36 , with thedelivery wire 156 held in place, thedelivery sheath 154 is withdrawn proximally to expose thedistal side 30 of the occluder and thedelivery catheter 152 is pushed towards thedistal tip 39 of the occluder to deploy thedistal side 30 of the occluder. Referring now toFIG. 37 , theproximal side 40 of the occluder is exposed by further withdrawing thedelivery sheath 154 proximally, while holding thedelivery catheter 152 and thedelivery wire 156 in place. Theproximal side 40 of the occluder is deployed by advancing thedelivery catheter 152 distally. Alternatively, theproximal side 40 of the occluder is deployed by withdrawing thedelivery wire 156 proximally. - Referring to
FIG. 38 , upon full deployment of the occluder and satisfaction with its position, the occluder is released by unscrewing thedelivery catheter 152 from the threadedportion 150 of the occluder, then unscrewing thedelivery wire 156 from the threadedportion 417 of thecatch tube 402, and finally withdrawing thedelivery catheter 152,delivery sheath 154, anddelivery wire 156 proximally. Once thedelivery wire 156 is unscrewed from the threadedportion 417 and withdrawn, thecatch member 400 is released into its deployed configuration withprotrusions 404 formed. - The components of alternate embodiments of the
catch member 400 described supra are described in connection withFIGS. 39-42 . -
FIG. 39 illustrates thecatch member 400 withprotrusions 444 in the deployed configuration biased towards thedistal side 408 of thecatch tube 402. This biasing can be achieved by modification of the manufacturing process, a step of which is illustrated inFIG. 33 .FIG. 40 illustrates thecatch member 400 withprotrusions 454 in the deployed configuration biased towards theproximal side 406 of thecatch tube 402. This biasing can be achieved by modification of the manufacturing process, a step of which is illustrated inFIG. 33 . In particular, annealing can be used to create alternate shapes. -
FIG. 41 illustrates yet another alternative embodiment of thecatch member 400. In this embodiment, slits 463 are cut at an angle θ with respect to the axis of thecatch tube 402. When forces are applied to compress theproximal side 406 and thedistal side 408 of thecatch tube 402, as illustrated for example inFIG. 33 , theproximal side 406 will twist with respect to thedistal side 408, which will result inprotrusions 464 having a twisted shape as illustrated inFIG. 42 . -
FIGS. 43A, 43B and 44 illustrate another embodiment of the invention. In this embodiment, acatch system 600 includes a temporary and a permanent catch that are achieved by abump 601 on the proximal portion of a catch system, for example a catch tube by the use of two threads of different pitches. During manufacture of the catch system,bump 601 is formed on the proximal side of the tube by a material processing technique such as annealing. The use of two different pitches allows the catch member to be elongated in a delivery (reduced profile) configuration when a delivery wire is attached to the catch member. As the delivery wire is unscrewed from the catch member, the bump re-forms to provide a catch. -
FIG. 43A illustrates a cross-section of the proximal portion of the catch member during the deployment stage. The proximal end of the catch member, proximal to bump 601, rests on the proximal section of thedelivery wire 604. Aproximal section 605 of thedelivery wire 604 has a larger diameter than the distal section of thedelivery wire 606. The difference in diameters can be smaller or larger than the difference illustrated inFIGS. 43A, 43B and 44. In one embodiment, diameters of the proximal section of thedelivery wire 604 and the distal section of thedelivery wire 606 may be nearly identical. - Still referring to
FIG. 43A , a delivery wire has a smaller diameter at itsdistal section 606 and a larger diameter at itsproximal section 604. The difference in diameters can be smaller or larger than the difference illustrated inFIGS. 43A, 43B , and 44. The proximal side of thedelivery wire 604 has athread 614 and the distal side of thedelivery wire 606 has athread 616. Theproximal end 602 of thecatch member 600 has amatching thread 612 tothread 614 of the same pitch. Thedistal end 603 of the catch member has amatching thread 613 tothread 616 of the same pitch.Thread 614 has a larger pitch thanthread 616, by at least 0.01 of an inch. - During the occluder delivery process, the
delivery wire 605 is advanced distally by threadably connecting threadedportion 613 of thedelivery wire 605 and the threadedportion 616 of thecatch member 600, and threadedportion 614 of thedelivery wire 605 and the threadedportion 612 of thecatch member 600. Because threadedportions portions proximal end 602 advancing in the direction, indicated by arrow A relative to thedelivery wire 605, faster than thedistal end 603. Bump 601 of thecatch member 600 is therefore elongated, and thecatch member 600 is reduced to its delivery profile. The resultant configuration is illustrated inFIG. 43B . -
FIG. 43B illustrates the catch member in the delivery stage of the deployment process. In this delivery configuration,bump 601 is reduced to a lower-profile configuration, allowing for a device, such as an occluder, to slide more easily overbump 601. In this configuration, with thedelivery wire 605 still attached, thecatch member 600 could temporarily catch the occluder during its deployment with its proximal section of larger diameter. This may be useful during deployment, retrieval, repositioning or evaluation of deployment of an occluder. Once this is satisfactory, thedelivery wire 605 can be removed by withdrawing it proximally. Removal of thedelivery wire 605 results in theproximal end 602 moving in direction B faster than thedistal end 603, creating the high-profile configuration ofbump 601 as illustrated inFIG. 44 . Generally, it may be desirable that this be accomplished in 1-10 turns, more preferably within 3-5 turns. Examples of suitable pitches include 0.011 inch pitch for threadedportion 613 of thecatch member 600 and threadedportion 616 of the threadedwire 605, and 0.030 inch pitch for threadedportion 612 of thecatch member 600 and threadedportion 614 of the threadedwire 605, or 0.011 inch pitch for threadedportion 613 of thecatch member 600 and threadedportion 616 of the threadedwire 605, and 0.025 inch pitch for threadedportion 612 of thecatch member 600 and threadedportion 614 of the threadedwire 605. -
FIG. 44 illustrates the catch member once the delivery wire has been detached and removed, creating a permanent catch for the occluder at its deployed configuration. As a result of the pressure onbump 601, exerted by the proximal end of the occluder to be caught,proximal end 602 of thecatch member 600 may constrict, for example atthreads 612, and create a permanent catch. Alternatively, the material may provide sufficient stability to allow the bump to maintain the device in the delivered configuration. - Materials suitable for use with this embodiment include materials that are able to be easily deformed, for example metals, alloys, polymers, or combinations of these and similar materials. Examples include, but are not limited to, bioabsorbable polymers such as polyhydroxyalkanoate compositions such as poly-4-hydroxybutyrate, bioabsorbable metals such as iron and magnesium.
-
FIG. 45A illustrates a step in the manufacture of the catch member according to one aspect of the disclosure.Catch tube 502 is illustrated withlumen 503,steps 510,tabs 514 andlumens 505, located at theproximal side 506 of the catch member.Tabs 514 andsteps 510 can be made of the same piece of material ascatch tube 502, or they can be separate pieces made from the same, or different material. The vertical spacing betweensteps 510 is equal or slightly larger than the height oftabs 514 to allowtabs 514 to slide betweensteps 510 without leaving more than a minimal clearance betweensteps 510 andtabs 514. Bump 504 (e.g. as shown inFIG. 45B ) can be created, for example by compressing the proximal anddistal ends FIG. 33 . -
FIG. 45B illustrates an embodiment of the catch member in a permanent catch configuration.Bump 504 has an outside diameter D1, which is larger than diameter oftube 502. Alternate bump configurations, including, but not limited to arms, barbs or other protrusions, are also encompassed by this disclosure.Tabs 514 are preformed, for example by annealing, into a curvilinear shape (although other suitable shapes also possible), such that when the catch member is not in contact with any other object (such as a delivery wire or an occluder),tabs 510 slide betweensteps 510 throughlumen 505, so thattab tips 515 protrude intolumen 503. One function oftab tips 515 protruding into the lumen is to prevent thebump 504 from being compressed. This configuration can provide a permanent catch. This configuration is further illustrated inFIG. 45D , which is a view alonglines 45D-45D inFIG. 45B . Another view of the same configuration is illustrated inFIG. 45F , which is a view alonglines 45F-45F inFIG. 45D .FIG. 45H is a view along lines 45G-45G inFIG. 45D .FIG. 45H illustrates howtabs 514 prevent compression of the proximal side of thecatch member 506 by sliding betweensteps 510. Therefore, application of pressure onbump 504 does not result in a substantively compressed configuration, also referred to as the temporary catch configuration, illustrated inFIGS. 45C, 45E , 45G and 45I. - A temporary catch configuration may be desired during deployment, retrieval, repositioning or evaluation of deployment of a device, such as an occluder. As illustrated in
FIG. 45C , the proximal end of thecatch member 506 can be compressed in a direction that reduces the volume oflumen 503. The vertical dimension oflumens 505 is larger than the height oftabs 514, to allow for compression oflumens 505 when tabs 514 (or tab tips 515) occupylumens 505 as illustrated. This compressed configuration enables a device, or a portion of a device, such as a proximal portion of anoccluder 520 with an inner diameter D4, to reversibly slide overbump 504 by exerting enough force onbump 504 to compress theproximal side 506 of the catch member. In the compressed configuration,bump 504 has an outer diameter D2, which is smaller than diameter D1 (illustrated inFIG. 45B ). A temporary catch configuration generally requires that the distal end of the delivery wire (not shown) occupies the distal portion oflumen 503. -
FIG. 45E is a view alonglines 45E-45E inFIG. 45C , which further illustrates the temporary catch configuration.Delivery wire 516 is attached to the catch member and occupies a portion oflumen 503.Tab tips 515 rub against thedelivery wire 516 and are pushed out oflumen 503 as illustrated. The curvilinear shape oftabs 514 results intabs 514 curving around the outside ofsteps 510, allowing the proximal side of thecatch member 506 to be compressed so thatbump 504 has outside diameter D2. This configuration is further illustrated inFIG. 45G , which is a view along lines 45G-45G inFIG. 45E .FIG. 45I illustrates howtabs 514 allow compression of the proximal side of thecatch member 506 by being positioned outside ofsteps 510. Therefore application of pressure onbump 504 will result in a compressed configuration. - In embodiments of the invention, including the embodiments specifically illustrated and described herein, the catching configuration can be temporary or permanent. A temporary catch configuration generally allows for the catch member to release, while a permanent catch configuration generally is not designed for release. Certain embodiments have both a temporary catch configuration, which allows for confirmation of proper deployment, and a permanent catch configuration, that is engaged when proper deployment is confirmed. A permanent catch configuration can, for example, have a greater diameter at the proximal end of the catch member than a temporary catch configuration and may be engaged only after the device has been properly positioned. A temporary catch configuration is generally preferred during evaluation and repositioning of a device, such as an occluder, while a permanent catch configuration is generally preferred once the device is deployed.
- The embodiments and techniques described here are described preferably for use with a device made of a polymer and formed from a single tube, such that the tube is a single monolithic material. The catch mechanism can be all or partly monolithic or integral with the tubular structure, or there can be an absence of any type of bonding or rigid connection to the rest of the tubular structure, in which case there may be some spring force or other force that holds the locking mechanism in place. While the device is thus shown as being substantially formed from a single tubular body, the catch mechanism as described in the embodiments above could be used with other types of devices, including those formed from many pieces, and including devices formed from other materials, including metals, polymers, stainless steel or nitinol.
- The term “bioabsorbable,” as used in the description above, is also understood to mean “bioresorbable.”
- While the description above refers to wires, and while the term “wire” might convey a more rigid piece than a string, a suture or a filament, all these terms are essentially interchangeable, and further include embodiments in which the wire, string, suture or filament is a hollow tube or conduit to allow another wire, as needed, to pass through its longitudinal axis. Each wire, string, suture and filament can be composed of one or more wires, strings, sutures and filaments.
- In cases in which the device is made of a polymer, it can be desirable to add an additive or coating to the material to make it radiopaque to make it more visible in a wider variety of imaging techniques.
- It will be appreciated that while a particular sequence of steps has been shown and described for purposes of explanation, the sequence may be varied in certain respects, or the steps may be combined, while still obtaining the desired deployment or in some cases to effect deployment in a particular way. For example, the delivery sheath may be advanced or retracted at varying times and in varying degrees, the proximal and distal portions of the occluder may be deployed into the petal configuration in a different sequence, etc. In addition, the steps could be automated.
Claims (25)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/644,373 US20070167981A1 (en) | 2005-12-22 | 2006-12-21 | Catch members for occluder devices |
US14/078,330 US9084603B2 (en) | 2005-12-22 | 2013-11-12 | Catch members for occluder devices |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75368105P | 2005-12-22 | 2005-12-22 | |
US11/644,373 US20070167981A1 (en) | 2005-12-22 | 2006-12-21 | Catch members for occluder devices |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/078,330 Division US9084603B2 (en) | 2005-12-22 | 2013-11-12 | Catch members for occluder devices |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070167981A1 true US20070167981A1 (en) | 2007-07-19 |
Family
ID=37808289
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/644,373 Abandoned US20070167981A1 (en) | 2005-12-22 | 2006-12-21 | Catch members for occluder devices |
US14/078,330 Active US9084603B2 (en) | 2005-12-22 | 2013-11-12 | Catch members for occluder devices |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/078,330 Active US9084603B2 (en) | 2005-12-22 | 2013-11-12 | Catch members for occluder devices |
Country Status (3)
Country | Link |
---|---|
US (2) | US20070167981A1 (en) |
EP (1) | EP1962695A1 (en) |
WO (1) | WO2007073566A1 (en) |
Cited By (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040073242A1 (en) * | 2002-06-05 | 2004-04-15 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure device with radial and circumferential support |
US20040087968A1 (en) * | 2002-10-25 | 2004-05-06 | Nmt Medical, Inc. | Expandable sheath tubing |
US20050251154A1 (en) * | 2004-05-06 | 2005-11-10 | Nmt Medical, Inc. | Double coil occluder |
US20070244518A1 (en) * | 2003-07-14 | 2007-10-18 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US20070250081A1 (en) * | 2006-03-31 | 2007-10-25 | Nmt Medical, Inc. | Adjustable length patent foramen ovale (PFO) occluder and catch system |
US20080086168A1 (en) * | 2006-09-28 | 2008-04-10 | Ryan Cahill | Implant-catheter attachment mechanism using snare and method of use |
US20090088795A1 (en) * | 2007-09-28 | 2009-04-02 | Nmt Medical, Inc. | Catch Member for Septal Occluder with Adjustable-Length Center Joint |
US20090240326A1 (en) * | 2005-10-26 | 2009-09-24 | Cardiosolutions | Implant Delivery and Deployment System and Method |
US20100022948A1 (en) * | 2008-06-13 | 2010-01-28 | Cardiosolutions | Steerable Catheter and Dilator and System and Method for Implanting a Heart Implant |
US7678123B2 (en) | 2003-07-14 | 2010-03-16 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US20100114156A1 (en) * | 2008-10-30 | 2010-05-06 | Abbott Vascular Inc. | Closure device |
US7867250B2 (en) | 2001-12-19 | 2011-01-11 | Nmt Medical, Inc. | Septal occluder and associated methods |
US7871419B2 (en) | 2004-03-03 | 2011-01-18 | Nmt Medical, Inc. | Delivery/recovery system for septal occluder |
US7963952B2 (en) | 2003-08-19 | 2011-06-21 | Wright Jr John A | Expandable sheath tubing |
US8257389B2 (en) | 2004-05-07 | 2012-09-04 | W.L. Gore & Associates, Inc. | Catching mechanisms for tubular septal occluder |
US8277480B2 (en) | 2005-03-18 | 2012-10-02 | W.L. Gore & Associates, Inc. | Catch member for PFO occluder |
US8308760B2 (en) | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
US8361110B2 (en) | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
CN102895008A (en) * | 2012-09-28 | 2013-01-30 | 乐普(北京)医疗器械股份有限公司 | Medical occluder and delivery system thereof |
US8449606B2 (en) | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US8480730B2 (en) | 2007-05-14 | 2013-07-09 | Cardiosolutions, Inc. | Solid construct mitral spacer |
US20130178889A1 (en) * | 2009-06-17 | 2013-07-11 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US8486136B2 (en) | 2005-10-26 | 2013-07-16 | Cardiosolutions, Inc. | Mitral spacer |
US20130245650A1 (en) * | 2008-01-29 | 2013-09-19 | Insightra Medical, Inc. | Fortified mesh for tissue repair |
US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
US8597347B2 (en) | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
US20140039542A1 (en) * | 2012-01-26 | 2014-02-06 | Endoshape, Inc. | Systems, Devices, And Methods for Delivering A Lumen Occlusion Device Using Distal And/Or Proximal Control |
US8753362B2 (en) | 2003-12-09 | 2014-06-17 | W.L. Gore & Associates, Inc. | Double spiral patent foramen ovale closure clamp |
US8758403B2 (en) | 2001-12-19 | 2014-06-24 | W.L. Gore & Associates, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
US8764848B2 (en) | 2004-09-24 | 2014-07-01 | W.L. Gore & Associates, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
US8778017B2 (en) | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US8814947B2 (en) | 2006-03-31 | 2014-08-26 | W.L. Gore & Associates, Inc. | Deformable flap catch mechanism for occluder device |
US8828049B2 (en) | 2004-04-09 | 2014-09-09 | W.L. Gore & Associates, Inc. | Split ends closure device and methods of use |
US20140296798A1 (en) * | 2011-07-15 | 2014-10-02 | Nanyang Technological University | Occlusion device for closing anatomical defects |
US8852270B2 (en) | 2007-11-15 | 2014-10-07 | Cardiosolutions, Inc. | Implant delivery system and method |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
US8888844B2 (en) | 2005-10-26 | 2014-11-18 | Cardiosolutions, Inc. | Heart valve implant |
US20150057662A1 (en) * | 2013-08-26 | 2015-02-26 | Wisconsin Alumni Research Foundation | Stent apparatus and method |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
US9017373B2 (en) | 2002-12-09 | 2015-04-28 | W.L. Gore & Associates, Inc. | Septal closure devices |
JP2015119991A (en) * | 2008-07-15 | 2015-07-02 | ピナンブラ、インク | Embolic coil implant system |
US9138562B2 (en) | 2007-04-18 | 2015-09-22 | W.L. Gore & Associates, Inc. | Flexible catheter system |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
US9241695B2 (en) | 2002-03-25 | 2016-01-26 | W.L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure clips |
US9259317B2 (en) | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US9271707B2 (en) | 2003-01-30 | 2016-03-01 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9295469B2 (en) | 2002-06-04 | 2016-03-29 | Abbott Vascular Inc. | Blood vessel closure clip and delivery device |
US9314230B2 (en) | 2009-01-09 | 2016-04-19 | Abbott Vascular Inc. | Closure device with rapidly eroding anchor |
US9320522B2 (en) | 2000-12-07 | 2016-04-26 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US9332976B2 (en) | 2011-11-30 | 2016-05-10 | Abbott Cardiovascular Systems, Inc. | Tissue closure device |
US9351716B2 (en) | 2009-06-17 | 2016-05-31 | Coherex Medical, Inc. | Medical device and delivery system for modification of left atrial appendage and methods thereof |
US9364209B2 (en) | 2012-12-21 | 2016-06-14 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US9398914B2 (en) | 2003-01-30 | 2016-07-26 | Integrated Vascular Systems, Inc. | Methods of use of a clip applier |
US9402625B2 (en) | 2000-09-08 | 2016-08-02 | Abbott Vascular Inc. | Surgical stapler |
US9414820B2 (en) | 2009-01-09 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9414824B2 (en) | 2009-01-16 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9474517B2 (en) | 2008-03-07 | 2016-10-25 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
US9486191B2 (en) | 2009-01-09 | 2016-11-08 | Abbott Vascular, Inc. | Closure devices |
US9498196B2 (en) | 2002-02-21 | 2016-11-22 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US20160345943A1 (en) * | 2014-04-30 | 2016-12-01 | Lepu Medical Technology (Beijing) Co., Ltd | Medical closure system |
US9545305B2 (en) | 2013-06-14 | 2017-01-17 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9554786B2 (en) | 2000-12-07 | 2017-01-31 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US9572584B2 (en) | 2009-01-08 | 2017-02-21 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9585647B2 (en) | 2009-08-26 | 2017-03-07 | Abbott Laboratories | Medical device for repairing a fistula |
US9649115B2 (en) | 2009-06-17 | 2017-05-16 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9693780B2 (en) | 2009-06-17 | 2017-07-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
US9795387B2 (en) | 1997-05-19 | 2017-10-24 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US20170319189A1 (en) * | 2012-02-29 | 2017-11-09 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US9962144B2 (en) | 2006-06-28 | 2018-05-08 | Abbott Laboratories | Vessel closure device |
US10064628B2 (en) | 2009-06-17 | 2018-09-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10085753B2 (en) | 2005-07-01 | 2018-10-02 | Abbott Laboratories | Clip applier and methods of use |
US10111664B2 (en) | 2000-01-05 | 2018-10-30 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US10413295B2 (en) | 2008-05-16 | 2019-09-17 | Abbott Laboratories | Engaging element for engaging tissue |
US10420565B2 (en) | 2016-11-29 | 2019-09-24 | Abbott Cardiovascular Systems Inc. | Cinch and post for tricuspid valve repair |
US10548614B2 (en) | 2016-11-29 | 2020-02-04 | Evalve, Inc. | Tricuspid valve repair system |
US10631969B2 (en) | 2009-06-17 | 2020-04-28 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
WO2020144283A1 (en) * | 2019-01-10 | 2020-07-16 | Ls Medcap Gmbh | Occluder insertion system |
US10792025B2 (en) | 2009-06-22 | 2020-10-06 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US10806437B2 (en) | 2009-06-22 | 2020-10-20 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
US10952852B2 (en) | 2017-02-24 | 2021-03-23 | Abbott Cardiovascular Systems Inc. | Double basket assembly for valve repair |
US10993807B2 (en) | 2017-11-16 | 2021-05-04 | Medtronic Vascular, Inc. | Systems and methods for percutaneously supporting and manipulating a septal wall |
US11058411B2 (en) * | 2019-01-14 | 2021-07-13 | Valfix Medical Ltd. | Anchors and locks for percutaneous valve implants |
US20210236102A1 (en) * | 2020-02-03 | 2021-08-05 | St. Jude Medical, Cardiology Division, Inc. | Occluder locking mechanisms |
US11311281B2 (en) * | 2017-04-06 | 2022-04-26 | Lifetech Scientific (Shenzhen) Co., Ltd | Occluder and occlusion device |
US11364033B2 (en) | 2018-02-20 | 2022-06-21 | Boston Scientific Scimed, Inc. | Medical device release system |
US11369355B2 (en) | 2019-06-17 | 2022-06-28 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
US20220218321A1 (en) * | 2019-07-18 | 2022-07-14 | Gunze Limited | Medical material |
US11389170B2 (en) | 2016-09-16 | 2022-07-19 | Endoshape, Inc. | Occlusive implants with fiber-based release structures |
US11534303B2 (en) | 2020-04-09 | 2022-12-27 | Evalve, Inc. | Devices and systems for accessing and repairing a heart valve |
US11812969B2 (en) | 2020-12-03 | 2023-11-14 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7625392B2 (en) | 2006-02-03 | 2009-12-01 | James Coleman | Wound closure devices and methods |
WO2008115922A1 (en) | 2007-03-19 | 2008-09-25 | Michael Brenzel | Methods and apparatus for occlusion of body lumens |
US9301761B2 (en) | 2007-10-22 | 2016-04-05 | James E. Coleman | Anastomosis devices and methods |
US8197498B2 (en) | 2008-11-06 | 2012-06-12 | Trinitas Ventures Ltd. | Gastric bypass devices and procedures |
US9247930B2 (en) | 2011-12-21 | 2016-02-02 | James E. Coleman | Devices and methods for occluding or promoting fluid flow |
Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US3875648A (en) * | 1973-04-04 | 1975-04-08 | Dennison Mfg Co | Fastener attachment apparatus and method |
US4006747A (en) * | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
US4007743A (en) * | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US4915107A (en) * | 1988-03-09 | 1990-04-10 | Harley International Medical Ltd. | Automatic instrument for purse-string sutures for surgical use |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
US5078736A (en) * | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5192301A (en) * | 1989-01-17 | 1993-03-09 | Nippon Zeon Co., Ltd. | Closing plug of a defect for medical use and a closing plug device utilizing it |
US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5284488A (en) * | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5304184A (en) * | 1992-10-19 | 1994-04-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
US5312341A (en) * | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
US5312435A (en) * | 1993-05-17 | 1994-05-17 | Kensey Nash Corporation | Fail predictable, reinforced anchor for hemostatic puncture closure |
US5411481A (en) * | 1992-04-08 | 1995-05-02 | American Cyanamid Co. | Surgical purse string suturing instrument and method |
US5413584A (en) * | 1992-05-11 | 1995-05-09 | Ethicon, Inc. | "Omega"-shaped staple for surgical, especially endoscopic, purposes |
US5417699A (en) * | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5480424A (en) * | 1993-11-01 | 1996-01-02 | Cox; James L. | Heart valve replacement using flexible tubes |
US5486193A (en) * | 1992-01-22 | 1996-01-23 | C. R. Bard, Inc. | System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder |
US5507811A (en) * | 1993-11-26 | 1996-04-16 | Nissho Corporation | Prosthetic device for atrial septal defect repair |
US5601571A (en) * | 1994-05-17 | 1997-02-11 | Moss; Gerald | Surgical fastener implantation device |
US5620461A (en) * | 1989-05-29 | 1997-04-15 | Muijs Van De Moer; Wouter M. | Sealing device |
US5709707A (en) * | 1995-10-30 | 1998-01-20 | Children's Medical Center Corporation | Self-centering umbrella-type septal closure device |
US5720754A (en) * | 1989-08-16 | 1998-02-24 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5733337A (en) * | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5741297A (en) * | 1996-08-28 | 1998-04-21 | Simon; Morris | Daisy occluder and method for septal defect repair |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US5865791A (en) * | 1995-06-07 | 1999-02-02 | E.P. Technologies Inc. | Atrial appendage stasis reduction procedure and devices |
US5879366A (en) * | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US5893856A (en) * | 1996-06-12 | 1999-04-13 | Mitek Surgical Products, Inc. | Apparatus and method for binding a first layer of material to a second layer of material |
US5902319A (en) * | 1997-09-25 | 1999-05-11 | Daley; Robert J. | Bioabsorbable staples |
US6010517A (en) * | 1996-04-10 | 2000-01-04 | Baccaro; Jorge Alberto | Device for occluding abnormal vessel communications |
US6024756A (en) * | 1996-03-22 | 2000-02-15 | Scimed Life Systems, Inc. | Method of reversibly closing a septal defect |
US6030007A (en) * | 1997-07-07 | 2000-02-29 | Hughes Electronics Corporation | Continually adjustable nonreturn knot |
US6171329B1 (en) * | 1994-12-19 | 2001-01-09 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6174322B1 (en) * | 1997-08-08 | 2001-01-16 | Cardia, Inc. | Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum |
US6187039B1 (en) * | 1996-12-10 | 2001-02-13 | Purdue Research Foundation | Tubular submucosal graft constructs |
US6190353B1 (en) * | 1995-10-13 | 2001-02-20 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
US6206907B1 (en) * | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
US6206895B1 (en) * | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6214029B1 (en) * | 2000-04-26 | 2001-04-10 | Microvena Corporation | Septal defect occluder |
US6217590B1 (en) * | 1999-01-22 | 2001-04-17 | Scion International, Inc. | Surgical instrument for applying multiple staples and cutting blood vessels and organic structures and method therefor |
US6221092B1 (en) * | 1998-03-30 | 2001-04-24 | Nissho Corporation | Closure device for transcatheter operations and catheter assembly therefor |
US6334872B1 (en) * | 1994-02-18 | 2002-01-01 | Organogenesis Inc. | Method for treating diseased or damaged organs |
US20020010481A1 (en) * | 1999-12-23 | 2002-01-24 | Swaminathan Jayaraman | Occlusive coil manufacture and delivery |
US6342064B1 (en) * | 1998-12-22 | 2002-01-29 | Nipro Corporation | Closure device for transcatheter operation and catheter assembly therefor |
US6344049B1 (en) * | 1999-08-17 | 2002-02-05 | Scion Cardio-Vascular, Inc. | Filter for embolic material mounted on expandable frame and associated deployment system |
US6344048B1 (en) * | 1997-07-10 | 2002-02-05 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6346074B1 (en) * | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
US20020019648A1 (en) * | 2000-04-19 | 2002-02-14 | Dan Akerfeldt | Intra-arterial occluder |
US6348041B1 (en) * | 1999-03-29 | 2002-02-19 | Cook Incorporated | Guidewire |
US20020026208A1 (en) * | 2000-01-05 | 2002-02-28 | Medical Technology Group, Inc. | Apparatus and methods for delivering a closure device |
US6352552B1 (en) * | 2000-05-02 | 2002-03-05 | Scion Cardio-Vascular, Inc. | Stent |
US20020029048A1 (en) * | 2000-09-01 | 2002-03-07 | Arnold Miller | Endovascular fastener and grafting apparatus and method |
US6356782B1 (en) * | 1998-12-24 | 2002-03-12 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6355052B1 (en) * | 1996-02-09 | 2002-03-12 | Pfm Produkte Fur Die Medizin Aktiengesellschaft | Device for closure of body defect openings |
US20020032459A1 (en) * | 1990-06-20 | 2002-03-14 | Danforth Biomedical, Inc. | Radially-expandable tubular elements for use in the construction of medical devices |
US20020032462A1 (en) * | 1998-06-10 | 2002-03-14 | Russell A. Houser | Thermal securing anastomosis systems |
US20020035374A1 (en) * | 2000-09-21 | 2002-03-21 | Borillo Thomas E. | Apparatus for implanting devices in atrial appendages |
US6364853B1 (en) * | 2000-09-11 | 2002-04-02 | Scion International, Inc. | Irrigation and suction valve and method therefor |
US6371904B1 (en) * | 1998-12-24 | 2002-04-16 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US20020043307A1 (en) * | 1998-06-26 | 2002-04-18 | Kiyoshito Ishida | Core wire for a guide wire comprising a functionally graded alloy |
US6375671B1 (en) * | 1999-04-19 | 2002-04-23 | Nipro Corporation | Closure device for transcatheter operations |
US6375625B1 (en) * | 2000-10-18 | 2002-04-23 | Scion Valley, Inc. | In-line specimen trap and method therefor |
US6379342B1 (en) * | 1999-04-02 | 2002-04-30 | Scion International, Inc. | Ampoule for dispensing medication and method of use |
US6379368B1 (en) * | 1999-05-13 | 2002-04-30 | Cardia, Inc. | Occlusion device with non-thrombogenic properties |
US20030004533A1 (en) * | 2001-05-04 | 2003-01-02 | Concentric Medical | Bioactive polymer vaso-occlusive device |
US6508828B1 (en) * | 2000-11-03 | 2003-01-21 | Radi Medical Systems Ab | Sealing device and wound closure device |
US6514515B1 (en) * | 1999-03-04 | 2003-02-04 | Tepha, Inc. | Bioabsorbable, biocompatible polymers for tissue engineering |
US20030028213A1 (en) * | 2001-08-01 | 2003-02-06 | Microvena Corporation | Tissue opening occluder |
US20030045893A1 (en) * | 2001-09-06 | 2003-03-06 | Integrated Vascular Systems, Inc. | Clip apparatus for closing septal defects and methods of use |
US20030050665A1 (en) * | 2001-09-07 | 2003-03-13 | Integrated Vascular Systems, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20030055455A1 (en) * | 2001-09-20 | 2003-03-20 | Scimed Life Systems, Inc. | Method and apparatus for treating septal defects |
US20030059640A1 (en) * | 1999-11-19 | 2003-03-27 | Denes Marton | High strength vacuum deposited nitinol alloy films and method of making same |
US20030065379A1 (en) * | 1994-04-29 | 2003-04-03 | Babbs Charles F. | Reduction of stent thrombogenicity |
US6548569B1 (en) * | 1999-03-25 | 2003-04-15 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
US6551344B2 (en) * | 2000-04-26 | 2003-04-22 | Ev3 Inc. | Septal defect occluder |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US20030150821A1 (en) * | 1999-07-16 | 2003-08-14 | Bates Mark C. | Emboli filtration system and methods of use |
US6689589B2 (en) * | 1997-09-19 | 2004-02-10 | Metabolix, Inc. | Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
US20040044361A1 (en) * | 1998-11-06 | 2004-03-04 | Frazier Andrew G.C. | Detachable atrial appendage occlusion balloon |
US6712836B1 (en) * | 1999-05-13 | 2004-03-30 | St. Jude Medical Atg, Inc. | Apparatus and methods for closing septal defects and occluding blood flow |
US6712804B2 (en) * | 1999-09-20 | 2004-03-30 | Ev3 Sunnyvale, Inc. | Method of closing an opening in a wall of the heart |
US20040073242A1 (en) * | 2002-06-05 | 2004-04-15 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure device with radial and circumferential support |
US6726696B1 (en) * | 2001-04-24 | 2004-04-27 | Advanced Catheter Engineering, Inc. | Patches and collars for medical applications and methods of use |
US20040167566A1 (en) * | 2003-02-24 | 2004-08-26 | Scimed Life Systems, Inc. | Apparatus for anchoring an intravascular device along a guidewire |
US20050025809A1 (en) * | 2003-07-08 | 2005-02-03 | Tepha, Inc. | Poly-4-hydroxybutyrate matrices for sustained drug delivery |
US20050043759A1 (en) * | 2003-07-14 | 2005-02-24 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US6867248B1 (en) * | 1997-05-12 | 2005-03-15 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
US20050273135A1 (en) * | 2004-05-07 | 2005-12-08 | Nmt Medical, Inc. | Catching mechanisms for tubular septal occluder |
US20070010851A1 (en) * | 2003-07-14 | 2007-01-11 | Chanduszko Andrzej J | Tubular patent foramen ovale (PFO) closure device with catch system |
US7198631B2 (en) * | 2000-09-01 | 2007-04-03 | Medtronic Angiolink, Inc. | Advanced wound site management systems and methods |
Family Cites Families (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3924631A (en) | 1973-12-06 | 1975-12-09 | Altair Inc | Magnetic clamp |
JPS6171065A (en) | 1984-09-13 | 1986-04-11 | テルモ株式会社 | Catheter introducer |
US4696300A (en) | 1985-04-11 | 1987-09-29 | Dennison Manufacturing Company | Fastener for joining materials |
US4626245A (en) | 1985-08-30 | 1986-12-02 | Cordis Corporation | Hemostatis valve comprising an elastomeric partition having opposed intersecting slits |
US4710192A (en) | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
US5478353A (en) | 1987-05-14 | 1995-12-26 | Yoon; Inbae | Suture tie device system and method for suturing anatomical tissue proximate an opening |
US5250430A (en) | 1987-06-29 | 1993-10-05 | Massachusetts Institute Of Technology | Polyhydroxyalkanoate polymerase |
US5245023A (en) | 1987-06-29 | 1993-09-14 | Massachusetts Institute Of Technology | Method for producing novel polyester biopolymers |
US4836204A (en) | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
US4840623A (en) | 1988-02-01 | 1989-06-20 | Fbk International Corporation | Medical catheter with splined internal wall |
US4956178A (en) | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
US5149327A (en) | 1989-09-05 | 1992-09-22 | Terumo Kabushiki Kaisha | Medical valve, catheter with valve, and catheter assembly |
US5226879A (en) | 1990-03-01 | 1993-07-13 | William D. Ensminger | Implantable access device |
US5171259A (en) | 1990-04-02 | 1992-12-15 | Kanji Inoue | Device for nonoperatively occluding a defect |
US5021059A (en) | 1990-05-07 | 1991-06-04 | Kensey Nash Corporation | Plug device with pulley for sealing punctures in tissue and methods of use |
US5037433A (en) | 1990-05-17 | 1991-08-06 | Wilk Peter J | Endoscopic suturing device and related method and suture |
US5041129A (en) | 1990-07-02 | 1991-08-20 | Acufex Microsurgical, Inc. | Slotted suture anchor and method of anchoring a suture |
US5152144A (en) | 1990-09-19 | 1992-10-06 | Cummins Engine Company, Inc. | Air to air heat exchanger internal bypass |
JPH04170966A (en) | 1990-11-01 | 1992-06-18 | Nippon Sherwood Kk | Valvular body for catheter introducer blood stop valve |
US5257637A (en) | 1991-03-22 | 1993-11-02 | El Gazayerli Mohamed M | Method for suture knot placement and tying |
CA2082090C (en) | 1991-11-05 | 2004-04-27 | Jack Fagan | Improved occluder for repair of cardiac and vascular defects |
DE69229539T2 (en) | 1991-11-05 | 2000-02-17 | Children's Medical Center Corp., Boston | Occlusion device for repairing heart and vascular defects |
US5222974A (en) | 1991-11-08 | 1993-06-29 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
WO1993013712A1 (en) | 1992-01-21 | 1993-07-22 | Regents Of The University Of Minnesota | Septal defect closure device |
US5236440A (en) | 1992-04-14 | 1993-08-17 | American Cyanamid Company | Surgical fastener |
US5540712A (en) | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5354308A (en) | 1992-05-01 | 1994-10-11 | Beth Israel Hospital Association | Metal wire stent |
US6653291B1 (en) | 1992-11-13 | 2003-11-25 | Purdue Research Foundation | Composition and method for production of transformed cells |
US5350363A (en) | 1993-06-14 | 1994-09-27 | Cordis Corporation | Enhanced sheath valve |
DE69523615T3 (en) | 1994-04-06 | 2006-09-21 | William Cook Europe A/S | A MEDICAL DEVICE FOR IMPLANTING IN THE VASCULAR SYSTEM OF A HUMAN |
EP1217101B8 (en) | 1994-04-29 | 2006-02-01 | Boston Scientific Scimed, Inc. | Stent with collagen |
US5453095A (en) | 1994-06-07 | 1995-09-26 | Cordis Corporation | One piece self-aligning, self-lubricating catheter valve |
US5433727A (en) | 1994-08-16 | 1995-07-18 | Sideris; Eleftherios B. | Centering buttoned device for the occlusion of large defects for occluding |
DE9413645U1 (en) | 1994-08-24 | 1994-10-27 | Schneidt, Bernhard, Ing.(grad.), 63571 Gelnhausen | Device for closing a duct, in particular the ductus arteriosus |
US5577299A (en) | 1994-08-26 | 1996-11-26 | Thompson; Carl W. | Quick-release mechanical knot apparatus |
US5618311A (en) | 1994-09-28 | 1997-04-08 | Gryskiewicz; Joseph M. | Surgical subcuticular fastener system |
US5702421A (en) | 1995-01-11 | 1997-12-30 | Schneidt; Bernhard | Closure device for closing a vascular opening, such as patent ductus arteriosus |
US5634936A (en) | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5649959A (en) | 1995-02-10 | 1997-07-22 | Sherwood Medical Company | Assembly for sealing a puncture in a vessel |
US5711969A (en) | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
US6322548B1 (en) | 1995-05-10 | 2001-11-27 | Eclipse Surgical Technologies | Delivery catheter system for heart chamber |
US5957953A (en) | 1996-02-16 | 1999-09-28 | Smith & Nephew, Inc. | Expandable suture anchor |
US5755791A (en) | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
WO1997041778A1 (en) | 1996-05-08 | 1997-11-13 | Salviac Limited | An occluder device |
US6488706B1 (en) | 1996-05-08 | 2002-12-03 | Carag Ag | Device for plugging an opening such as in a wall of a hollow or tubular organ |
US6143037A (en) | 1996-06-12 | 2000-11-07 | The Regents Of The University Of Michigan | Compositions and methods for coating medical devices |
US5690674A (en) | 1996-07-02 | 1997-11-25 | Cordis Corporation | Wound closure with plug |
US5800516A (en) | 1996-08-08 | 1998-09-01 | Cordis Corporation | Deployable and retrievable shape memory stent/tube and method |
AU4082497A (en) | 1996-08-22 | 1998-03-06 | Trustees Of Columbia University, The | Endovascular flexible stapling device |
US5776183A (en) | 1996-08-23 | 1998-07-07 | Kanesaka; Nozomu | Expandable stent |
US5810884A (en) | 1996-09-09 | 1998-09-22 | Beth Israel Deaconess Medical Center | Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject |
US5755778A (en) | 1996-10-16 | 1998-05-26 | Nitinol Medical Technologies, Inc. | Anastomosis device |
GB2318795B (en) | 1996-10-28 | 1999-08-25 | Bardon | Remediation of domestic waste incinerator residue |
US5944691A (en) | 1996-11-04 | 1999-08-31 | Cordis Corporation | Catheter having an expandable shaft |
DE69730039T2 (en) | 1996-11-05 | 2005-07-14 | Purdue Research Foundation, West Lafayette | HEART transplants |
CA2272097C (en) | 1996-12-10 | 2007-02-20 | Purdue Research Foundation | Artificial vascular valves |
AU5621198A (en) | 1996-12-30 | 1998-07-31 | Imagyn Medical Technologies, Inc. | Expandable access device and method of constructing and using same |
US5776162A (en) | 1997-01-03 | 1998-07-07 | Nitinol Medical Technologies, Inc. | Vessel implantable shape memory appliance with superelastic hinged joint |
JP3134288B2 (en) | 1997-01-30 | 2001-02-13 | 株式会社ニッショー | Endocardial suture surgery tool |
JP3134287B2 (en) | 1997-01-30 | 2001-02-13 | 株式会社ニッショー | Catheter assembly for endocardial suture surgery |
US5993844A (en) | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
US6610764B1 (en) | 1997-05-12 | 2003-08-26 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
PT981381E (en) | 1997-05-12 | 2007-04-30 | Metabolix Inc | Polyhydroxyalkanoates for in vivo applications |
US6071292A (en) | 1997-06-28 | 2000-06-06 | Transvascular, Inc. | Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures |
DE69840594D1 (en) | 1997-07-22 | 2009-04-09 | Metabolix Inc | POLYHYDROXYALKANOATE MOLDING |
US6828357B1 (en) | 1997-07-31 | 2004-12-07 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
ES2272007T3 (en) | 1997-08-04 | 2007-04-16 | Boston Scientific Limited | OCLUSION SYSTEM FOR PREPARATION OF AN ANEURISM. |
US6077880A (en) | 1997-08-08 | 2000-06-20 | Cordis Corporation | Highly radiopaque polyolefins and method for making the same |
WO1999018862A1 (en) | 1997-10-10 | 1999-04-22 | Hearten Medical, Inc. | A catheter device for abrading a patent foramen ovale and method of using the device |
US6106913A (en) | 1997-10-10 | 2000-08-22 | Quantum Group, Inc | Fibrous structures containing nanofibrils and other textile fibers |
AU1077799A (en) | 1997-10-10 | 1999-05-03 | Hearten Medical, Inc. | A catheter for causing thermal trauma to a patent foramen ovale and method of using the catheter |
AU9604498A (en) | 1997-10-10 | 1999-05-03 | Hearten Medical, Inc. | A balloon catheter for abrading a patent foramen ovale and method of using the balloon catheter |
WO1999018870A1 (en) | 1997-10-10 | 1999-04-22 | Hearten Medical, Inc. | A balloon catheter for causing thermal trauma to a patent foramen ovale and method of using the balloon catheter |
US5989268A (en) | 1997-10-28 | 1999-11-23 | Boston Scientific Corporation | Endoscopic hemostatic clipping device |
US5976174A (en) | 1997-12-15 | 1999-11-02 | Ruiz; Carlos E. | Medical hole closure device and methods of use |
US6036720A (en) | 1997-12-15 | 2000-03-14 | Target Therapeutics, Inc. | Sheet metal aneurysm neck bridge |
US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
US5993475A (en) | 1998-04-22 | 1999-11-30 | Bristol-Myers Squibb Co. | Tissue repair device |
US6113609A (en) | 1998-05-26 | 2000-09-05 | Scimed Life Systems, Inc. | Implantable tissue fastener and system for treating gastroesophageal reflux disease |
US7452371B2 (en) | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
US6265333B1 (en) | 1998-06-02 | 2001-07-24 | Board Of Regents, University Of Nebraska-Lincoln | Delamination resistant composites prepared by small diameter fiber reinforcement at ply interfaces |
US6165183A (en) | 1998-07-15 | 2000-12-26 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US5919200A (en) | 1998-10-09 | 1999-07-06 | Hearten Medical, Inc. | Balloon catheter for abrading a patent foramen ovale and method of using the balloon catheter |
US6183496B1 (en) | 1998-11-02 | 2001-02-06 | Datascope Investment Corp. | Collapsible hemostatic plug |
US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
US6228097B1 (en) | 1999-01-22 | 2001-05-08 | Scion International, Inc. | Surgical instrument for clipping and cutting blood vessels and organic structures |
WO2000044428A1 (en) | 1999-01-28 | 2000-08-03 | Ansamed Limited | Catheter with an expandable end portion |
US6231589B1 (en) * | 1999-03-22 | 2001-05-15 | Microvena Corporation | Body vessel filter |
US6277139B1 (en) | 1999-04-01 | 2001-08-21 | Scion Cardio-Vascular, Inc. | Vascular protection and embolic material retriever |
US6426145B1 (en) | 1999-05-20 | 2002-07-30 | Scimed Life Systems, Inc. | Radiopaque compositions for visualization of medical devices |
US6488689B1 (en) | 1999-05-20 | 2002-12-03 | Aaron V. Kaplan | Methods and apparatus for transpericardial left atrial appendage closure |
US6165204A (en) | 1999-06-11 | 2000-12-26 | Scion International, Inc. | Shaped suture clip, appliance and method therefor |
US6494888B1 (en) | 1999-06-22 | 2002-12-17 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6306424B1 (en) | 1999-06-30 | 2001-10-23 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
US6398796B2 (en) | 1999-07-13 | 2002-06-04 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6245080B1 (en) | 1999-07-13 | 2001-06-12 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US7892246B2 (en) | 1999-07-28 | 2011-02-22 | Bioconnect Systems, Inc. | Devices and methods for interconnecting conduits and closing openings in tissue |
CA2383595A1 (en) | 1999-09-20 | 2001-03-29 | Erik J. Van Der Burg | Method and apparatus for closing a body lumen |
US6387104B1 (en) | 1999-11-12 | 2002-05-14 | Scimed Life Systems, Inc. | Method and apparatus for endoscopic repair of the lower esophageal sphincter |
US20010041914A1 (en) | 1999-11-22 | 2001-11-15 | Frazier Andrew G.C. | Tissue patch deployment catheter |
DE10000137A1 (en) | 2000-01-04 | 2001-07-12 | Pfm Prod Fuer Die Med Ag | Implantate for closing defect apertures in human or animal bodies, bearing structure of which can be reversed from secondary to primary form by elastic force |
US20010034567A1 (en) | 2000-01-20 | 2001-10-25 | Allen Marc L. | Remote management of retail petroleum equipment |
US6227139B1 (en) | 2000-03-16 | 2001-05-08 | The United States Of America As Represented By The Secretary Of The Navy | Control tab assisted lift reducing system for underwater hydrofoil surface |
US6650923B1 (en) | 2000-04-13 | 2003-11-18 | Ev3 Sunnyvale, Inc. | Method for accessing the left atrium of the heart by locating the fossa ovalis |
US7056294B2 (en) | 2000-04-13 | 2006-06-06 | Ev3 Sunnyvale, Inc | Method and apparatus for accessing the left atrial appendage |
US6599448B1 (en) | 2000-05-10 | 2003-07-29 | Hydromer, Inc. | Radio-opaque polymeric compositions |
US6334864B1 (en) | 2000-05-17 | 2002-01-01 | Aga Medical Corp. | Alignment member for delivering a non-symmetric device with a predefined orientation |
ATE329048T1 (en) | 2000-07-21 | 2006-06-15 | Metabolix Inc | PRODUCTION OF POLYHYDROXYALKANOATES FROM POLYOLS |
US6440152B1 (en) | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
WO2002017809A1 (en) | 2000-08-29 | 2002-03-07 | Kaplan Aaron V | Methods and apparatus for transpericardial left atrial appendage closure |
US6699278B2 (en) | 2000-09-22 | 2004-03-02 | Cordis Corporation | Stent with optimal strength and radiopacity characteristics |
JP2004508884A (en) | 2000-09-25 | 2004-03-25 | コヒージョン テクノロジーズ, インコーポレイテッド | Resorbable anastomotic stent and plug |
US6666861B1 (en) | 2000-10-05 | 2003-12-23 | James R. Grabek | Atrial appendage remodeling device and method |
US6629901B2 (en) | 2000-11-09 | 2003-10-07 | Ben Huang | Composite grip for golf clubs |
US6746404B2 (en) | 2000-12-18 | 2004-06-08 | Biosense, Inc. | Method for anchoring a medical device between tissue |
US20020128680A1 (en) | 2001-01-25 | 2002-09-12 | Pavlovic Jennifer L. | Distal protection device with electrospun polymer fiber matrix |
US6550480B2 (en) | 2001-01-31 | 2003-04-22 | Numed/Tech Llc | Lumen occluders made from thermodynamic materials |
US20020107531A1 (en) | 2001-02-06 | 2002-08-08 | Schreck Stefan G. | Method and system for tissue repair using dual catheters |
US6623518B2 (en) | 2001-02-26 | 2003-09-23 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
US6921410B2 (en) | 2001-05-29 | 2005-07-26 | Scimed Life Systems, Inc. | Injection molded vaso-occlusive elements |
US6537300B2 (en) | 2001-05-30 | 2003-03-25 | Scimed Life Systems, Inc. | Implantable obstruction device for septal defects |
US7338514B2 (en) | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
US6941169B2 (en) | 2001-06-04 | 2005-09-06 | Albert Einstein Healthcare Network | Cardiac stimulating apparatus having a blood clot filter and atrial pacer |
US6585755B2 (en) | 2001-06-29 | 2003-07-01 | Advanced Cardiovascular | Polymeric stent suitable for imaging by MRI and fluoroscopy |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
US7867250B2 (en) | 2001-12-19 | 2011-01-11 | Nmt Medical, Inc. | Septal occluder and associated methods |
EP1471835A4 (en) | 2002-01-14 | 2008-03-19 | Nmt Medical Inc | Patent foramen ovale (pfo) closure method and device |
EP1487353A4 (en) | 2002-03-25 | 2008-04-16 | Nmt Medical Inc | Patent foramen ovale (pfo) closure clips |
US20040127855A1 (en) | 2002-10-10 | 2004-07-01 | Nmt Medical, Inc. | Hemostasis valve |
WO2004037333A1 (en) | 2002-10-25 | 2004-05-06 | Nmt Medical, Inc. | Expandable sheath tubing |
AU2003287554A1 (en) | 2002-11-06 | 2004-06-03 | Nmt Medical, Inc. | Medical devices utilizing modified shape memory alloy |
ATE420593T1 (en) | 2002-11-07 | 2009-01-15 | Nmt Medical Inc | CLOSURE OF PERSONAL SEPTUM DAMAGE USING MAGNETIC FORCE |
AU2003294682A1 (en) | 2002-12-09 | 2004-06-30 | Nmt Medical, Inc. | Septal closure devices |
CA2429314A1 (en) | 2003-05-22 | 2004-11-22 | Richard A. Dawson | Collapsible shield for smoking animal lure |
ATE413898T1 (en) | 2003-08-19 | 2008-11-15 | Nmt Medical Inc | EXPANDABLE LOCK HOSE |
WO2005092203A1 (en) | 2004-03-03 | 2005-10-06 | Nmt Medical, Inc. | Delivery/recovery system for septal occluder |
US7704268B2 (en) | 2004-05-07 | 2010-04-27 | Nmt Medical, Inc. | Closure device with hinges |
EP1827247B8 (en) | 2004-09-24 | 2020-05-06 | W.L. Gore & Associates, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
US7931671B2 (en) * | 2005-03-11 | 2011-04-26 | Radi Medical Systems Ab | Medical sealing device |
EP1868507A1 (en) * | 2005-03-18 | 2007-12-26 | NMT Medical, Inc. | Catch member for pfo occluder |
-
2006
- 2006-12-21 WO PCT/US2006/062512 patent/WO2007073566A1/en active Application Filing
- 2006-12-21 EP EP06846765A patent/EP1962695A1/en not_active Withdrawn
- 2006-12-21 US US11/644,373 patent/US20070167981A1/en not_active Abandoned
-
2013
- 2013-11-12 US US14/078,330 patent/US9084603B2/en active Active
Patent Citations (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US3875648A (en) * | 1973-04-04 | 1975-04-08 | Dennison Mfg Co | Fastener attachment apparatus and method |
US4006747A (en) * | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
US4007743A (en) * | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
US4425908A (en) * | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4915107A (en) * | 1988-03-09 | 1990-04-10 | Harley International Medical Ltd. | Automatic instrument for purse-string sutures for surgical use |
US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
US5192301A (en) * | 1989-01-17 | 1993-03-09 | Nippon Zeon Co., Ltd. | Closing plug of a defect for medical use and a closing plug device utilizing it |
US5620461A (en) * | 1989-05-29 | 1997-04-15 | Muijs Van De Moer; Wouter M. | Sealing device |
US5720754A (en) * | 1989-08-16 | 1998-02-24 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5078736A (en) * | 1990-05-04 | 1992-01-07 | Interventional Thermodynamics, Inc. | Method and apparatus for maintaining patency in the body passages |
US20020032459A1 (en) * | 1990-06-20 | 2002-03-14 | Danforth Biomedical, Inc. | Radially-expandable tubular elements for use in the construction of medical devices |
US5108420A (en) * | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5486193A (en) * | 1992-01-22 | 1996-01-23 | C. R. Bard, Inc. | System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder |
US5626599A (en) * | 1992-01-22 | 1997-05-06 | C. R. Bard | Method for the percutaneous transluminal front-end loading delivery of a prosthetic occluder |
US5411481A (en) * | 1992-04-08 | 1995-05-02 | American Cyanamid Co. | Surgical purse string suturing instrument and method |
US5413584A (en) * | 1992-05-11 | 1995-05-09 | Ethicon, Inc. | "Omega"-shaped staple for surgical, especially endoscopic, purposes |
US5312341A (en) * | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
US5304184A (en) * | 1992-10-19 | 1994-04-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US5417699A (en) * | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5284488A (en) * | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US6346074B1 (en) * | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
US5312435A (en) * | 1993-05-17 | 1994-05-17 | Kensey Nash Corporation | Fail predictable, reinforced anchor for hemostatic puncture closure |
US5480424A (en) * | 1993-11-01 | 1996-01-02 | Cox; James L. | Heart valve replacement using flexible tubes |
US5507811A (en) * | 1993-11-26 | 1996-04-16 | Nissho Corporation | Prosthetic device for atrial septal defect repair |
US6334872B1 (en) * | 1994-02-18 | 2002-01-01 | Organogenesis Inc. | Method for treating diseased or damaged organs |
US20030065379A1 (en) * | 1994-04-29 | 2003-04-03 | Babbs Charles F. | Reduction of stent thrombogenicity |
US5601571A (en) * | 1994-05-17 | 1997-02-11 | Moss; Gerald | Surgical fastener implantation device |
US5725552A (en) * | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US6171329B1 (en) * | 1994-12-19 | 2001-01-09 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US5733337A (en) * | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5865791A (en) * | 1995-06-07 | 1999-02-02 | E.P. Technologies Inc. | Atrial appendage stasis reduction procedure and devices |
US6190353B1 (en) * | 1995-10-13 | 2001-02-20 | Transvascular, Inc. | Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures |
US5709707A (en) * | 1995-10-30 | 1998-01-20 | Children's Medical Center Corporation | Self-centering umbrella-type septal closure device |
US6355052B1 (en) * | 1996-02-09 | 2002-03-12 | Pfm Produkte Fur Die Medizin Aktiengesellschaft | Device for closure of body defect openings |
US5733294A (en) * | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US6024756A (en) * | 1996-03-22 | 2000-02-15 | Scimed Life Systems, Inc. | Method of reversibly closing a septal defect |
US6010517A (en) * | 1996-04-10 | 2000-01-04 | Baccaro; Jorge Alberto | Device for occluding abnormal vessel communications |
US5893856A (en) * | 1996-06-12 | 1999-04-13 | Mitek Surgical Products, Inc. | Apparatus and method for binding a first layer of material to a second layer of material |
US5741297A (en) * | 1996-08-28 | 1998-04-21 | Simon; Morris | Daisy occluder and method for septal defect repair |
US5861003A (en) * | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US6187039B1 (en) * | 1996-12-10 | 2001-02-13 | Purdue Research Foundation | Tubular submucosal graft constructs |
US5879366A (en) * | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US6867248B1 (en) * | 1997-05-12 | 2005-03-15 | Metabolix, Inc. | Polyhydroxyalkanoate compositions having controlled degradation rates |
US6030007A (en) * | 1997-07-07 | 2000-02-29 | Hughes Electronics Corporation | Continually adjustable nonreturn knot |
US6344048B1 (en) * | 1997-07-10 | 2002-02-05 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6174322B1 (en) * | 1997-08-08 | 2001-01-16 | Cardia, Inc. | Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum |
US6689589B2 (en) * | 1997-09-19 | 2004-02-10 | Metabolix, Inc. | Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
US5902319A (en) * | 1997-09-25 | 1999-05-11 | Daley; Robert J. | Bioabsorbable staples |
US6221092B1 (en) * | 1998-03-30 | 2001-04-24 | Nissho Corporation | Closure device for transcatheter operations and catheter assembly therefor |
US20020032462A1 (en) * | 1998-06-10 | 2002-03-14 | Russell A. Houser | Thermal securing anastomosis systems |
US20020043307A1 (en) * | 1998-06-26 | 2002-04-18 | Kiyoshito Ishida | Core wire for a guide wire comprising a functionally graded alloy |
US20040044361A1 (en) * | 1998-11-06 | 2004-03-04 | Frazier Andrew G.C. | Detachable atrial appendage occlusion balloon |
US6342064B1 (en) * | 1998-12-22 | 2002-01-29 | Nipro Corporation | Closure device for transcatheter operation and catheter assembly therefor |
US6371904B1 (en) * | 1998-12-24 | 2002-04-16 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6356782B1 (en) * | 1998-12-24 | 2002-03-12 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6217590B1 (en) * | 1999-01-22 | 2001-04-17 | Scion International, Inc. | Surgical instrument for applying multiple staples and cutting blood vessels and organic structures and method therefor |
US6514515B1 (en) * | 1999-03-04 | 2003-02-04 | Tepha, Inc. | Bioabsorbable, biocompatible polymers for tissue engineering |
US6548569B1 (en) * | 1999-03-25 | 2003-04-15 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
US6838493B2 (en) * | 1999-03-25 | 2005-01-04 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
US6867247B2 (en) * | 1999-03-25 | 2005-03-15 | Metabolix, Inc. | Medical devices and applications of polyhydroxyalkanoate polymers |
US6348041B1 (en) * | 1999-03-29 | 2002-02-19 | Cook Incorporated | Guidewire |
US6379342B1 (en) * | 1999-04-02 | 2002-04-30 | Scion International, Inc. | Ampoule for dispensing medication and method of use |
US6375671B1 (en) * | 1999-04-19 | 2002-04-23 | Nipro Corporation | Closure device for transcatheter operations |
US6206907B1 (en) * | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
US6379368B1 (en) * | 1999-05-13 | 2002-04-30 | Cardia, Inc. | Occlusion device with non-thrombogenic properties |
US6712836B1 (en) * | 1999-05-13 | 2004-03-30 | St. Jude Medical Atg, Inc. | Apparatus and methods for closing septal defects and occluding blood flow |
US6206895B1 (en) * | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US20030150821A1 (en) * | 1999-07-16 | 2003-08-14 | Bates Mark C. | Emboli filtration system and methods of use |
US6344049B1 (en) * | 1999-08-17 | 2002-02-05 | Scion Cardio-Vascular, Inc. | Filter for embolic material mounted on expandable frame and associated deployment system |
US6712804B2 (en) * | 1999-09-20 | 2004-03-30 | Ev3 Sunnyvale, Inc. | Method of closing an opening in a wall of the heart |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US20030059640A1 (en) * | 1999-11-19 | 2003-03-27 | Denes Marton | High strength vacuum deposited nitinol alloy films and method of making same |
US20020010481A1 (en) * | 1999-12-23 | 2002-01-24 | Swaminathan Jayaraman | Occlusive coil manufacture and delivery |
US20020026208A1 (en) * | 2000-01-05 | 2002-02-28 | Medical Technology Group, Inc. | Apparatus and methods for delivering a closure device |
US20020019648A1 (en) * | 2000-04-19 | 2002-02-14 | Dan Akerfeldt | Intra-arterial occluder |
US6214029B1 (en) * | 2000-04-26 | 2001-04-10 | Microvena Corporation | Septal defect occluder |
US6551344B2 (en) * | 2000-04-26 | 2003-04-22 | Ev3 Inc. | Septal defect occluder |
US6352552B1 (en) * | 2000-05-02 | 2002-03-05 | Scion Cardio-Vascular, Inc. | Stent |
US7198631B2 (en) * | 2000-09-01 | 2007-04-03 | Medtronic Angiolink, Inc. | Advanced wound site management systems and methods |
US20020029048A1 (en) * | 2000-09-01 | 2002-03-07 | Arnold Miller | Endovascular fastener and grafting apparatus and method |
US6364853B1 (en) * | 2000-09-11 | 2002-04-02 | Scion International, Inc. | Irrigation and suction valve and method therefor |
US20020035374A1 (en) * | 2000-09-21 | 2002-03-21 | Borillo Thomas E. | Apparatus for implanting devices in atrial appendages |
US6375625B1 (en) * | 2000-10-18 | 2002-04-23 | Scion Valley, Inc. | In-line specimen trap and method therefor |
US6508828B1 (en) * | 2000-11-03 | 2003-01-21 | Radi Medical Systems Ab | Sealing device and wound closure device |
US6726696B1 (en) * | 2001-04-24 | 2004-04-27 | Advanced Catheter Engineering, Inc. | Patches and collars for medical applications and methods of use |
US20030004533A1 (en) * | 2001-05-04 | 2003-01-02 | Concentric Medical | Bioactive polymer vaso-occlusive device |
US20030028213A1 (en) * | 2001-08-01 | 2003-02-06 | Microvena Corporation | Tissue opening occluder |
US20030045893A1 (en) * | 2001-09-06 | 2003-03-06 | Integrated Vascular Systems, Inc. | Clip apparatus for closing septal defects and methods of use |
US20030050665A1 (en) * | 2001-09-07 | 2003-03-13 | Integrated Vascular Systems, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20030055455A1 (en) * | 2001-09-20 | 2003-03-20 | Scimed Life Systems, Inc. | Method and apparatus for treating septal defects |
US20040073242A1 (en) * | 2002-06-05 | 2004-04-15 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure device with radial and circumferential support |
US20040167566A1 (en) * | 2003-02-24 | 2004-08-26 | Scimed Life Systems, Inc. | Apparatus for anchoring an intravascular device along a guidewire |
US20050025809A1 (en) * | 2003-07-08 | 2005-02-03 | Tepha, Inc. | Poly-4-hydroxybutyrate matrices for sustained drug delivery |
US20050043759A1 (en) * | 2003-07-14 | 2005-02-24 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US20070010851A1 (en) * | 2003-07-14 | 2007-01-11 | Chanduszko Andrzej J | Tubular patent foramen ovale (PFO) closure device with catch system |
US20050273135A1 (en) * | 2004-05-07 | 2005-12-08 | Nmt Medical, Inc. | Catching mechanisms for tubular septal occluder |
Cited By (182)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9795387B2 (en) | 1997-05-19 | 2017-10-24 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10111664B2 (en) | 2000-01-05 | 2018-10-30 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US9402625B2 (en) | 2000-09-08 | 2016-08-02 | Abbott Vascular Inc. | Surgical stapler |
US9320522B2 (en) | 2000-12-07 | 2016-04-26 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US9554786B2 (en) | 2000-12-07 | 2017-01-31 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US9585646B2 (en) | 2000-12-07 | 2017-03-07 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US10245013B2 (en) | 2000-12-07 | 2019-04-02 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US7867250B2 (en) | 2001-12-19 | 2011-01-11 | Nmt Medical, Inc. | Septal occluder and associated methods |
US8758403B2 (en) | 2001-12-19 | 2014-06-24 | W.L. Gore & Associates, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
US10201340B2 (en) | 2002-02-21 | 2019-02-12 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US9498196B2 (en) | 2002-02-21 | 2016-11-22 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US9241695B2 (en) | 2002-03-25 | 2016-01-26 | W.L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure clips |
US9980728B2 (en) | 2002-06-04 | 2018-05-29 | Abbott Vascular Inc | Blood vessel closure clip and delivery device |
US9295469B2 (en) | 2002-06-04 | 2016-03-29 | Abbott Vascular Inc. | Blood vessel closure clip and delivery device |
US9028527B2 (en) | 2002-06-05 | 2015-05-12 | W.L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with radial and circumferential support |
US8784448B2 (en) | 2002-06-05 | 2014-07-22 | W.L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with radial and circumferential support |
US20040073242A1 (en) * | 2002-06-05 | 2004-04-15 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure device with radial and circumferential support |
US7766820B2 (en) | 2002-10-25 | 2010-08-03 | Nmt Medical, Inc. | Expandable sheath tubing |
US20040087968A1 (en) * | 2002-10-25 | 2004-05-06 | Nmt Medical, Inc. | Expandable sheath tubing |
US9017373B2 (en) | 2002-12-09 | 2015-04-28 | W.L. Gore & Associates, Inc. | Septal closure devices |
US9271707B2 (en) | 2003-01-30 | 2016-03-01 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US9398914B2 (en) | 2003-01-30 | 2016-07-26 | Integrated Vascular Systems, Inc. | Methods of use of a clip applier |
US10398418B2 (en) | 2003-01-30 | 2019-09-03 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US11589856B2 (en) | 2003-01-30 | 2023-02-28 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US7678123B2 (en) | 2003-07-14 | 2010-03-16 | Nmt Medical, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US11375988B2 (en) | 2003-07-14 | 2022-07-05 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US9149263B2 (en) | 2003-07-14 | 2015-10-06 | W. L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US20070244518A1 (en) * | 2003-07-14 | 2007-10-18 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US9326759B2 (en) | 2003-07-14 | 2016-05-03 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US7963952B2 (en) | 2003-08-19 | 2011-06-21 | Wright Jr John A | Expandable sheath tubing |
US8753362B2 (en) | 2003-12-09 | 2014-06-17 | W.L. Gore & Associates, Inc. | Double spiral patent foramen ovale closure clamp |
US7871419B2 (en) | 2004-03-03 | 2011-01-18 | Nmt Medical, Inc. | Delivery/recovery system for septal occluder |
US8945158B2 (en) | 2004-03-03 | 2015-02-03 | W.L. Gore & Associates, Inc. | Delivery/recovery system for septal occluder |
US8568431B2 (en) | 2004-03-03 | 2013-10-29 | W.L. Gore & Associates, Inc. | Delivery/recovery system for septal occluder |
US8828049B2 (en) | 2004-04-09 | 2014-09-09 | W.L. Gore & Associates, Inc. | Split ends closure device and methods of use |
US8361110B2 (en) | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
US20050251154A1 (en) * | 2004-05-06 | 2005-11-10 | Nmt Medical, Inc. | Double coil occluder |
US7842053B2 (en) | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
US8308760B2 (en) | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
US8568447B2 (en) | 2004-05-06 | 2013-10-29 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
US8480709B2 (en) | 2004-05-07 | 2013-07-09 | W.L. Gore & Associates, Inc. | Catching mechanisms for tubular septal occluder |
US9545247B2 (en) | 2004-05-07 | 2017-01-17 | W.L. Gore & Associates, Inc. | Catching mechanisms for tubular septal occluder |
US8257389B2 (en) | 2004-05-07 | 2012-09-04 | W.L. Gore & Associates, Inc. | Catching mechanisms for tubular septal occluder |
US8764848B2 (en) | 2004-09-24 | 2014-07-01 | W.L. Gore & Associates, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
US8277480B2 (en) | 2005-03-18 | 2012-10-02 | W.L. Gore & Associates, Inc. | Catch member for PFO occluder |
US8430907B2 (en) | 2005-03-18 | 2013-04-30 | W.L. Gore & Associates, Inc. | Catch member for PFO occluder |
US8636765B2 (en) | 2005-03-18 | 2014-01-28 | W.L. Gore & Associates, Inc. | Catch member for PFO occluder |
US11344304B2 (en) | 2005-07-01 | 2022-05-31 | Abbott Laboratories | Clip applier and methods of use |
US12070214B2 (en) | 2005-07-01 | 2024-08-27 | Abbott Laboratories | Clip applier and methods of use |
US10085753B2 (en) | 2005-07-01 | 2018-10-02 | Abbott Laboratories | Clip applier and methods of use |
US8778017B2 (en) | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US9232999B2 (en) | 2005-10-26 | 2016-01-12 | Cardiosolutions Inc. | Mitral spacer |
US8216302B2 (en) * | 2005-10-26 | 2012-07-10 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US8449606B2 (en) | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US8486136B2 (en) | 2005-10-26 | 2013-07-16 | Cardiosolutions, Inc. | Mitral spacer |
US8894705B2 (en) | 2005-10-26 | 2014-11-25 | Cardiosolutions, Inc. | Balloon mitral spacer |
US8888844B2 (en) | 2005-10-26 | 2014-11-18 | Cardiosolutions, Inc. | Heart valve implant |
US8506623B2 (en) | 2005-10-26 | 2013-08-13 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US20090240326A1 (en) * | 2005-10-26 | 2009-09-24 | Cardiosolutions | Implant Delivery and Deployment System and Method |
US9517129B2 (en) | 2005-10-26 | 2016-12-13 | Cardio Solutions, Inc. | Implant delivery and deployment system and method |
US8109946B2 (en) | 2006-03-31 | 2012-02-07 | W.L. Gore & Associates, Inc. | Adjustable length patent foramen ovale (PFO) occluder and catch system |
US8814947B2 (en) | 2006-03-31 | 2014-08-26 | W.L. Gore & Associates, Inc. | Deformable flap catch mechanism for occluder device |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
US20070250081A1 (en) * | 2006-03-31 | 2007-10-25 | Nmt Medical, Inc. | Adjustable length patent foramen ovale (PFO) occluder and catch system |
US9962144B2 (en) | 2006-06-28 | 2018-05-08 | Abbott Laboratories | Vessel closure device |
US8992545B2 (en) | 2006-09-28 | 2015-03-31 | W.L. Gore & Associates, Inc. | Implant-catheter attachment mechanism using snare and method of use |
US20080086168A1 (en) * | 2006-09-28 | 2008-04-10 | Ryan Cahill | Implant-catheter attachment mechanism using snare and method of use |
US10485525B2 (en) | 2007-04-05 | 2019-11-26 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
US12059140B2 (en) | 2007-04-05 | 2024-08-13 | W. L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
US9949728B2 (en) | 2007-04-05 | 2018-04-24 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
US9138562B2 (en) | 2007-04-18 | 2015-09-22 | W.L. Gore & Associates, Inc. | Flexible catheter system |
US8480730B2 (en) | 2007-05-14 | 2013-07-09 | Cardiosolutions, Inc. | Solid construct mitral spacer |
US8715319B2 (en) | 2007-09-28 | 2014-05-06 | W.L. Gore & Associates, Inc. | Catch member for septal occluder with adjustable-length center joint |
US20090088795A1 (en) * | 2007-09-28 | 2009-04-02 | Nmt Medical, Inc. | Catch Member for Septal Occluder with Adjustable-Length Center Joint |
US11154303B2 (en) | 2007-10-19 | 2021-10-26 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US8852270B2 (en) | 2007-11-15 | 2014-10-07 | Cardiosolutions, Inc. | Implant delivery system and method |
US8597347B2 (en) | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
US9770330B2 (en) | 2007-11-15 | 2017-09-26 | Cardiosolutions, Inc. | Implant delivery system and method |
US10159553B2 (en) * | 2008-01-29 | 2018-12-25 | Insightra Medical, Inc. | Fortified mesh for tissue repair |
US20130245650A1 (en) * | 2008-01-29 | 2013-09-19 | Insightra Medical, Inc. | Fortified mesh for tissue repair |
US9474517B2 (en) | 2008-03-07 | 2016-10-25 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
US10278705B2 (en) | 2008-03-07 | 2019-05-07 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
US10413295B2 (en) | 2008-05-16 | 2019-09-17 | Abbott Laboratories | Engaging element for engaging tissue |
US20100022948A1 (en) * | 2008-06-13 | 2010-01-28 | Cardiosolutions | Steerable Catheter and Dilator and System and Method for Implanting a Heart Implant |
US8591460B2 (en) | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
US9259317B2 (en) | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US9554805B2 (en) | 2008-07-15 | 2017-01-31 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US9775621B2 (en) | 2008-07-15 | 2017-10-03 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US11523830B2 (en) | 2008-07-15 | 2022-12-13 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US10405868B2 (en) | 2008-07-15 | 2019-09-10 | Penumbra, Inc. | Embolic coil implant system and implantation method |
JP2015119991A (en) * | 2008-07-15 | 2015-07-02 | ピナンブラ、インク | Embolic coil implant system |
US20100114156A1 (en) * | 2008-10-30 | 2010-05-06 | Abbott Vascular Inc. | Closure device |
US9241696B2 (en) * | 2008-10-30 | 2016-01-26 | Abbott Vascular Inc. | Closure device |
US9572584B2 (en) | 2009-01-08 | 2017-02-21 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10420564B2 (en) | 2009-01-08 | 2019-09-24 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9750505B2 (en) | 2009-01-08 | 2017-09-05 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10695070B2 (en) | 2009-01-08 | 2020-06-30 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10537313B2 (en) | 2009-01-09 | 2020-01-21 | Abbott Vascular, Inc. | Closure devices and methods |
US11439378B2 (en) | 2009-01-09 | 2022-09-13 | Abbott Cardiovascular Systems, Inc. | Closure devices and methods |
US9314230B2 (en) | 2009-01-09 | 2016-04-19 | Abbott Vascular Inc. | Closure device with rapidly eroding anchor |
US9486191B2 (en) | 2009-01-09 | 2016-11-08 | Abbott Vascular, Inc. | Closure devices |
US9414820B2 (en) | 2009-01-09 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9414824B2 (en) | 2009-01-16 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US10758240B2 (en) | 2009-06-17 | 2020-09-01 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10582929B2 (en) | 2009-06-17 | 2020-03-10 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US11540837B2 (en) | 2009-06-17 | 2023-01-03 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US20130178889A1 (en) * | 2009-06-17 | 2013-07-11 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10064628B2 (en) | 2009-06-17 | 2018-09-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10076337B2 (en) | 2009-06-17 | 2018-09-18 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9351716B2 (en) | 2009-06-17 | 2016-05-31 | Coherex Medical, Inc. | Medical device and delivery system for modification of left atrial appendage and methods thereof |
US9693781B2 (en) * | 2009-06-17 | 2017-07-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10631969B2 (en) | 2009-06-17 | 2020-04-28 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10537332B2 (en) | 2009-06-17 | 2020-01-21 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9649115B2 (en) | 2009-06-17 | 2017-05-16 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US11918227B2 (en) | 2009-06-17 | 2024-03-05 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10582930B2 (en) | 2009-06-17 | 2020-03-10 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US11253262B2 (en) | 2009-06-17 | 2022-02-22 | Coherex Medical, Inc. | Delivery device, system, and method thereof |
US9693780B2 (en) | 2009-06-17 | 2017-07-04 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10772637B2 (en) | 2009-06-17 | 2020-09-15 | Coherex Medical, Inc. | Medical device and delivery system for modification of left atrial appendage and methods thereof |
US11000289B2 (en) | 2009-06-17 | 2021-05-11 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US9883864B2 (en) | 2009-06-17 | 2018-02-06 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
US10806437B2 (en) | 2009-06-22 | 2020-10-20 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US12082795B2 (en) | 2009-06-22 | 2024-09-10 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US10792025B2 (en) | 2009-06-22 | 2020-10-06 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US11564672B2 (en) | 2009-06-22 | 2023-01-31 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US11596391B2 (en) | 2009-06-22 | 2023-03-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US11589853B2 (en) | 2009-06-22 | 2023-02-28 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9585647B2 (en) | 2009-08-26 | 2017-03-07 | Abbott Laboratories | Medical device for repairing a fistula |
US11154284B2 (en) * | 2011-07-15 | 2021-10-26 | Nanyang Technological University | Occlusion device for closing anatomical defects |
US20140296798A1 (en) * | 2011-07-15 | 2014-10-02 | Nanyang Technological University | Occlusion device for closing anatomical defects |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
JP2014534872A (en) * | 2011-11-01 | 2014-12-25 | コヒーレックス メディカル インコーポレイテッドCoherex Medical,Inc. | Medical device for left atrial appendage modification and related system and method |
US9332976B2 (en) | 2011-11-30 | 2016-05-10 | Abbott Cardiovascular Systems, Inc. | Tissue closure device |
US20140039542A1 (en) * | 2012-01-26 | 2014-02-06 | Endoshape, Inc. | Systems, Devices, And Methods for Delivering A Lumen Occlusion Device Using Distal And/Or Proximal Control |
US10206685B2 (en) | 2012-01-26 | 2019-02-19 | Endoshape, Inc. | Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control |
US9339275B2 (en) * | 2012-01-26 | 2016-05-17 | Endoshape, Inc. | Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control |
US20170319189A1 (en) * | 2012-02-29 | 2017-11-09 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US10966698B2 (en) * | 2012-02-29 | 2021-04-06 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
US11957328B2 (en) | 2012-02-29 | 2024-04-16 | Vivasure Medical Limited | Implants and methods for percutaneous perforation closure |
CN102895008A (en) * | 2012-09-28 | 2013-01-30 | 乐普(北京)医疗器械股份有限公司 | Medical occluder and delivery system thereof |
US9364209B2 (en) | 2012-12-21 | 2016-06-14 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US11672518B2 (en) | 2012-12-21 | 2023-06-13 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US10537312B2 (en) | 2012-12-21 | 2020-01-21 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
US11771408B2 (en) | 2013-01-18 | 2023-10-03 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
US9833316B2 (en) | 2013-03-15 | 2017-12-05 | Cardiosolutions, Inc. | Trans-apical implant systems, implants and methods |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9980812B2 (en) | 2013-06-14 | 2018-05-29 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9545305B2 (en) | 2013-06-14 | 2017-01-17 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9545272B2 (en) * | 2013-08-26 | 2017-01-17 | Wisconsin Alumni Research Foundation | Stent apparatus and method |
US20150057662A1 (en) * | 2013-08-26 | 2015-02-26 | Wisconsin Alumni Research Foundation | Stent apparatus and method |
US20160345943A1 (en) * | 2014-04-30 | 2016-12-01 | Lepu Medical Technology (Beijing) Co., Ltd | Medical closure system |
US10368853B2 (en) | 2014-06-06 | 2019-08-06 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US11298116B2 (en) | 2014-06-06 | 2022-04-12 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US11389170B2 (en) | 2016-09-16 | 2022-07-19 | Endoshape, Inc. | Occlusive implants with fiber-based release structures |
US10548614B2 (en) | 2016-11-29 | 2020-02-04 | Evalve, Inc. | Tricuspid valve repair system |
US10420565B2 (en) | 2016-11-29 | 2019-09-24 | Abbott Cardiovascular Systems Inc. | Cinch and post for tricuspid valve repair |
US10952852B2 (en) | 2017-02-24 | 2021-03-23 | Abbott Cardiovascular Systems Inc. | Double basket assembly for valve repair |
US11311281B2 (en) * | 2017-04-06 | 2022-04-26 | Lifetech Scientific (Shenzhen) Co., Ltd | Occluder and occlusion device |
US10993807B2 (en) | 2017-11-16 | 2021-05-04 | Medtronic Vascular, Inc. | Systems and methods for percutaneously supporting and manipulating a septal wall |
US11364033B2 (en) | 2018-02-20 | 2022-06-21 | Boston Scientific Scimed, Inc. | Medical device release system |
US20220387043A1 (en) * | 2019-01-10 | 2022-12-08 | Qatna Medical GmbH | Occluder insertion system |
CN115252037A (en) * | 2019-01-10 | 2022-11-01 | 卡特纳医疗有限公司 | Occluder insertion system |
EP4101397A3 (en) * | 2019-01-10 | 2023-01-11 | Qatna Medical GmbH | Occluder insertion system and insertion unit |
US11690630B2 (en) | 2019-01-10 | 2023-07-04 | Qatna Medical GmbH | Occluder insertion system |
WO2020144283A1 (en) * | 2019-01-10 | 2020-07-16 | Ls Medcap Gmbh | Occluder insertion system |
US11890019B2 (en) * | 2019-01-10 | 2024-02-06 | Qatna Medical GmbH | Occluder insertion system |
US11058411B2 (en) * | 2019-01-14 | 2021-07-13 | Valfix Medical Ltd. | Anchors and locks for percutaneous valve implants |
US11931021B2 (en) * | 2019-01-14 | 2024-03-19 | Valfix Medical Ltd. | Anchors and locks for percutaneous valve implants |
US20210290222A1 (en) * | 2019-01-14 | 2021-09-23 | Valfix Medical Ltd. | Anchors and locks for percutaneous valve implants |
US12102309B2 (en) | 2019-06-17 | 2024-10-01 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
US11369355B2 (en) | 2019-06-17 | 2022-06-28 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
US20220218321A1 (en) * | 2019-07-18 | 2022-07-14 | Gunze Limited | Medical material |
US20210236102A1 (en) * | 2020-02-03 | 2021-08-05 | St. Jude Medical, Cardiology Division, Inc. | Occluder locking mechanisms |
US11534303B2 (en) | 2020-04-09 | 2022-12-27 | Evalve, Inc. | Devices and systems for accessing and repairing a heart valve |
US11812969B2 (en) | 2020-12-03 | 2023-11-14 | Coherex Medical, Inc. | Medical device and system for occluding a tissue opening and method thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2007073566A1 (en) | 2007-06-28 |
EP1962695A1 (en) | 2008-09-03 |
US9084603B2 (en) | 2015-07-21 |
US20140222058A1 (en) | 2014-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9084603B2 (en) | Catch members for occluder devices | |
US8551135B2 (en) | Screw catch mechanism for PFO occluder and method of use | |
US8636765B2 (en) | Catch member for PFO occluder | |
US8870913B2 (en) | Catch system with locking cap for patent foramen ovale (PFO) occluder | |
US8814947B2 (en) | Deformable flap catch mechanism for occluder device | |
US8764848B2 (en) | Occluder device double securement system for delivery/recovery of such occluder device | |
US8109946B2 (en) | Adjustable length patent foramen ovale (PFO) occluder and catch system | |
US8715319B2 (en) | Catch member for septal occluder with adjustable-length center joint | |
US8992545B2 (en) | Implant-catheter attachment mechanism using snare and method of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NMT MEDICAL, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OPOLSKI, STEVEN W.;FORDE, SEAN T.;KLADAKIS, STEPHANIE M.;AND OTHERS;REEL/FRAME:019021/0096 Effective date: 20070301 |
|
AS | Assignment |
Owner name: W.L. GORE & ASSOCIATES, INC., ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NMT MEDICAL, INC. (BY AND THROUGH JOSEPH F. FINN, JR., AS ASSIGNEE FOR THE BENEFIT OF CREDITORS OF NMT MEDICAL, INC.);REEL/FRAME:026503/0273 Effective date: 20110616 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |